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 Mass spectrometry (MS) has advantages as an analytical technique including label-free 
detection, high degrees of specificity and selectivity, capability for simultaneous 
monitoring/determination of numerous analytes, and rapid ionization/analysis, though throughput 
and sensitivity improvements are regularly sought. As a result, MS is commonly interfaced with 
different technologies including separations. Capillary electrophoresis (CE) is often selected over 
liquid chromatography(LC) for advantages including low volume requirements and faster 
separations, though online preconcentration is often necessary to improve limits of detection 
(LODs). In this work, a powerful preconcentration technique is paired with CE-MS to obtain LODs 
down to 10 pM, addressing the sensitivity limitation. Preconcentration here was shown to improve 
LODs by 5000-fold compared to a typical hydrodynamic injection for CE-MS. This method was 
applied for simultaneous determination of seven neurochemicals in biological samples with an 
excellent linear dynamic range (pM-µM).  
 To improve throughputs, microfluidic sample introduction, especially droplet 
microfluidics, has shown promise for use with electrospray ionization (ESI)-MS, demonstrating 
sample introduction rates up to 30 Hz and droplet sizes down to 65 pL.1,2 In this dissertation, 
several droplet microfluidic assays are developed and paired with nanoelectrospray ionization 
(nESI) or ESI (droplet-nESI) for high throughput analyses. In one method, 5 nL droplets are 
generated at the end of a microdialysis probe to achieve temporal resolution near 10 s, substantially 
better than a standard LC-MS analysis with 5–20 min temporal resolution with microdialysis, 
offering much deeper insight into neurochemical dynamics. Using low flow nESI with MS/MS to 
xix 
 
overcome ionization suppression, we achieve low nM LODs (down to 2 nM) for simultaneous 
monitoring of seven neurochemicals, including trace neurotransmitters. This was applied to 
monitoring neurochemical dynamics in mouse brains in response to multiple drugs. 
In another method, droplet-nESI is used for high throughput screening in a directed enzyme 
evolution workflow. Directed evolution can provide much higher reaction yields, but screening 
can take weeks. Here, droplets are generated from well-plate reactions and infused into a sensitive 
nESI-MS/MS method to measure reaction yields with product LODs down to 12 nM. Over 1700 
reactions (> 550 in triplicate) are screened in a single day, and over 1700 reactions (in triplicate) 
are screened in total. Seven enzymes with higher enzymatic activity are identified while achieving 
10-fold higher throughput than LC-MS. 
Finally, a new mode of liquid-liquid extraction is developed called slug flow 
nanoextraction (SFNE) that uses only 5 nL of each phase per extraction, and partitioning 
equilibrium is reached within seconds while flowing in-line with a detector. This was applied for 
online sample clean-up of pharmaceuticals from biofluids in-line with MS/MS analysis, 
demonstrating nearly 20-fold-improvements in detection sensitivity with up to 60 extractions 
performed during a single infusion. Furthermore, an entirely online and automated system is 
developed for SFNE. This system is applied to screen 21 octanol-water partition coefficients (Kow) 
within 2 hr. Kows are an important physiochemical characteristic for understanding drug 
bioavailability, though current measurements are low-throughput. In a comparison, the developed 
method offers 10-fold higher throughput and 40-fold lower volume requirements than a typical 
workflow. 
 The work described in this dissertation, though diverse, pushes forward what can be 
performed with mass spectrometry and bioanalysis. Each chapter introduces an analytically novel 
xx 
 
or innovative approach for the analysis of small molecules that advances important fields of 
research including physiochemical characterization, high throughput screening with mass 



































Figure 1-1: Small molecules throughout the central dogma 
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 Understanding the role of small molecules in biological systems is crucial for progress in 
pharmaceutical 
development, 
diagnostics, and for a 
deeper understanding 
of many diseases and 
behaviors and their 
physiological 
implications (Figure 1-
1).3–5 Due to the broad 
presence of small 
molecules,  fields of research for a variety of small molecule classes have rapidly grown over the 
past decades, with special emphasis on metabolomics and lipidomics.6,7 These alone accounts for 
over 100,000 different small molecule compounds according to HMDB.8 
The growth of these fields has led to the development and application of many different 
instruments to monitor and measure small molecules, including NMR, LC-MS, GC-MS, CE-MS, 
and various modes of direct MS.7–12 Though each method has advantages, LC-MS has become the 
‘gold standard’ for metabolomics and lipidomics due to its quantitative capabilities, variable 
throughputs, automation, excellent metabolite coverage, and minimal sample preparation.13 
Figure 1-1: Illustration of the ubiquity of small molecules throughout the central dogma of biology. 




Utilizing a robust analytical separation technique such as HPLC before MS allows for a separation 
of small molecules from complex biological mixtures before detection allowing for more potential 
analytes to be identified, improved selectivity, and a better dynamic range. While separations like 
LC improves the ability to distinguish two similar analytes (a.k.a. selectivity),  MS as a detector 
allows for a high degree of specifictiy, often allowing compounds to be unambiguously identified 
from a complex mixture. 
Despite the numerous advantages of LC-MS in small molecule workflows, it has several 
shortcomings. These shortcomings include relatively large sample volume requirement ( > 5 µL), 
relatively low throughputs/long analysis time, and difficulty separating highly polar compounds 
(for RPLC). CE-MS is another important tool used for small molecule analysis that has many 
functional similarities to LC-MS, as well as some key advantages. Like LC-MS, CE-MS has 
become popular in metabolomics due to its automation, minimal sample preparation, variable 
throughputs, and excellent metabolome coverage, where CE-MS has been used to analyze 
biofluids and identify hundreds of metabolites per separation.12,14,15 CE-MS has many advantages 
to LC-MS, especially for metabolomics where electrophoresis is more suitable than RPLC for 
separating small, polar, charged analytes. Other advantages include low sample volume 
requirements, low buffer/solvent consumption, potential for rapid separations (ms – min), high 
efficiency/peak capacity, and the availability of various preconcentration techniques. Despite these 
advantages, CE-MS typically has poor detection sensitivity, and application of preconcentration 
techniques, though functional, can affect separation speed and/or resolution in the separation.  
Though LC-MS and CE-MS have many strong applications and uses, alternative mass 
spectrometry methods have gained popularity to overcome the shortcomings of LC-MS and CE-




analyzer due to its various possible combinations of ionization sources, mass analyzers, and front 
end separation/automated sample introduction techniques. Specifically, implementing ESI/nESI 
for ionization can provide much utility and has many advantages. 
Electrospray Ionization and Suppression 
 
Electrospray ionization is a robust technique, where an aqueous phase flows through a 
narrow piece of silica or metal ESI emitter to ensure analytes are charges and transfer analytes to 
the gas phase. As the flow reaches the narrowed tip of the emitter, a strong electric field from an 
applied voltage disperses the liquid into a fine mist of strongly charged droplets from the presence 
of excess small cations (H+, Na+, etc.) These excess cations are rapidly generated by 
electrochemical reactions occurring at the emitter tip, such as: 
2 H2O  →  4 H
+  +  4 e−  +  O2                                                        1                                                                                                            
where the ESI source acts as an electrochemical cell.18  According to the ion evaporation model 
(IEM) for small molecules, these micrometer diameter droplets from the initial mist shrink due to 
solvent evaporation/desolvation and coulombic repulsion induced fission events - due to the strong 
charge within the droplets - until they have reached the size of several nanometers and can 
successfully eject gas-phase ions due to coulombic repulsion to be mass analyzed (Figure 1-2).18–
20 These ejected gas-phase analytes are often lightly solvated and solvent molecules are generally 
removed as the ions enter the MS.21 Although, solvation of the ejected ion is often minimal or 
excluded when working with entirely aqueous solutions due to the high surface tension of water. 
 Being a flow-based ionization technique for liquid-phase samples, ESI has distinct 
advantages. ESI can be readily paired with liquid-phase separations, such as LC and CE – though 

































instrumentation (i.e. Agilent Rapidfire) or droplet microfluidics.22,23 Electrospray ionization is 
rapid, allowing for samples to be analyzed within seconds, and its ability to continuously ionize 
sample allows for constant sample introduction, or even to be paired with a continuous sampling 
technique such as microdialysis.24  
 A disadvantage of ESI is ionization suppression. Ionization suppression occurs readily in 
ESI due to several factors that hinder analytes either from gaining surface activity and charge or 
from properly desolvating.25 The main matrix effects that cause suppression are attributed to the 
presence of nonvolatile compounds, high concentration solutes, and competition for 
charge/surface activity from other present compounds.25–27 Low molecular weight species ionize 
during ESI via IEM, where lightly solvated ions are ejected from a sufficiently evaporated 
nanodroplet surface due to its high electric field.28 Figure 3 shows a theoretical distribution of 
compounds and charge within a nanodroplet. Observation of a molecule by a mass spectrometer 




is dependent on the molecule gaining surface activity within the nanodroplet and gaining or 
maintaining charge (via proton or other cation adducts), where it can be ejected into the gas phase 
and reach the detector. The likelihood of a specific molecule to ionize from a given solution is 
known as its ionization efficiency (E):  
ɛ =   
𝑖𝑜𝑛𝑠/𝑠𝑒𝑐𝑑𝑒𝑡𝑒𝑐𝑡𝑜𝑟
𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠/𝑠𝑒𝑐𝑒𝑚𝑖𝑡𝑡𝑒𝑑
                          
where ɛ is equal to the ions detected per second over the total analyte molecules emitted per 
second.29 The presence of any previously mentioned negative matrix effects, namely those 
impairing an analyte’s opportunity to gain surface activity, charge, and ejection, can drastically 
reduce an analytes ionization efficiency and have been shown to reduce signal intensity 
by up to two orders of magnitude.30  
ESI Sensitivity and Detection 
 
Electrospray ionization paired with mass spectrometry has powerful advantages for 
analysis and detection such as a high degree of specificity and resolution, rapid analysis times, and 
(a) (b) 
Figure 1-3: (A) Simulated image of a water nanodroplet (O red; H white) containing 10 Na+ ions (blue). (B) Illustration of the 
distribution of ions and water dipoles inside of a nanodroplet, showing the effect of competing solvation requirements and dipole 


































label-free capabilities; however, it often has relatively high limits of detection (LOD). High LOD 
can be especially challenging when working with biological samples and endogenous small 
molecule analytes. Ionization suppression due to matrix effects is highly present in complex 
mixtures, such as biofluids, due to the presence of high salt concentrations, proteins, hydrophobic 
compounds, and a myriad of other compounds present in varying concentrations. These competing 
matrix effects can make the detection of low concentration analytes difficult or impossible.31 
Several techniques have been used to overcome ionization suppression and improve upon the 
relatively low ionization efficiency of standard ESI. These techniques include liquid-phase 
extractions, solid-phase extractions, front-end separations, and nESI with lowered flow rates. 
Utilizing different forms of ESI or similar modes of ionization is one way to improve detection 
limits, the most notable of which is nanoelectrospray ionization (nESI), which can greatly improve 
ionization efficiency and reduce matrix effects for improved LODs.32  
Using lowered flow rates (nL/min) and smaller diameter emitters ( < 50 µm) is a variation 
of electrospray ionization deemed nESI that has been shown to drastically reduce ionization 
suppression and improve ionization efficiency, among other benefits.29,33 These improvements 
mainly occur due to the generation of smaller initial droplets during electrospray (< µm diameter) 
resulting from the lower infusion flow rates and smaller tip diameters. Smaller nanodroplets offer 
a larger surface area-to-volume ratio, increasing the opportunity of a given ion to gain surface 
activity by providing increased accessible surface area and reduced distance from the droplet 
interior to the surface. These differences can greatly benefit complex matrices which often have 
many molecules competing for surface activity. It has been shown that lowering the flow rates 
substantially alleviates ionization suppression, and suppression is essentially absent once flow 




smaller the resulting nanodroplets will be. Using nESI can also drastically improve the base 
ionization efficiency (ε). For example, in a study comparing conventional ESI to nESI, ε of 
0.0005% was obtained for ESI and ε of 0.26% was obtained for nESI, a 512 fold-improvement by 
nESI.35 The ε can be further improved through the use of even lower flow rates, where ε of 5% has 
been achieved when working near 1 nL/min infusion rates, and ε up to 12% was reported.29 nESI 
offers several advantages including increased overall ionization efficiency, higher efficiency for 
completely aqueous solutions, reduced sample volume requirements, and minimized ionization 
suppression,34,36 and it has grown rapidly in popularity and implementation since its development 
in 199437 due to these abundant advantages. Additionally, nESI has facilitated MS interfacing with 
low flow techniques such as capillary electrophoresis.38  
Another common method for improving LODs by ESI-MS is to perform an extraction to 
cleanup samples before ESI. Sample cleanup is often executed using offline liquid-liquid 
extractions or solid-phase extractions before analysis.39,40 The utility of extractions for MS has led 
to the development of many extraction techniques for improving MS sensitivity including online 
SPE/SPME, coated blade spray ionization, packed-ESI tips, parallel artificial liquid membrane 
extraction, and others. 41–45 Other than extractions, other pretreatments such as using sample 
additives, dilutions, or chemical derivatization46 can effectively improve LODs by improving 
ionization efficiency or reducing the strength of matrix effects. 
 The implementation of LC or CE prior to ESI-MS is another common and effective way to 
improve LODs, especially when exploiting their ability to perform preconcentration on samples 
before MS analysis. LC-MS performs preconcentration using its ability to load several column 
volumes worth of sample onto the front of the packed bed, offering drastically improved LODs 




providing insufficient LODs in many applications, especially with UV-Vis absorbance and MS 
detection due to small pathlengths and minute injection volumes.While capillary zone 
electrophoresis (CZE) alone paired with ESI-MS struggles with sensitivity, there is an abundance 
of applicable CE sample cleanup and preconcentration techniques.48,49 Several online sample 
cleanup techniques have been used with CE-MS. These techniques, such as microelectromembrane 
extractions and polarity reversing, function by desalting the sample, allowing for reduced 
ionization suppression.32,50  
Additionally, dozens of online CE preconcentration techniques exist, which can provide 
signal enhancement by up to four orders of magnitude.48,49 Many of these techniques have been 
paired with ESI-MS, and have been shown to offer up to a three order of magnitude improvement 
in LODs when paired with ESI-MS.51 CE can also offer benefits due to its inherently low flow 
rates, making it highly suitable for pairing with nESI. This allows for efficient separation while 
benefiting from the improved ionization efficiency of nESI.52 Furthermore, preconcentration can 
be combined with CE-nESI-MS for even further enhancements.  
All of the techniques described above have been used to improve LODs and sensitivity of 
ESI-MS. The use of some of these techniques has allowed for LODs down to the pM range by 
ESI-MS. ESI is continually explored and improved upon due to its many advantages as an 
ionization technique, as previously mentioned. Another one of its important advantages is the 
potential for rapid analysis and high throughput sample introduction for mass spectrometry. 
ESI Throughput 
 
 Electrospray ionization is a rapid ionization technique, able to emit thousands of molecules 




milliseconds.29,53,54 Consequently, ESI has become an important ionization technique for rapid 
analysis, able to interface with many different instruments and techniques for improved sample 
introduction rates.53 Being a liquid phase and flow-based ionization source, ESI is often paired 
with LC. However, despite its core importance across many analytical applications, LC-MS has a 
couple of prominent limitations. These limitations most importantly include large sample volume 
requirements ( > 5 µL) and low throughputs. LC separations can take minutes to hours to perform, 
making it very low throughput compared to more rapid separations or sample introduction 
techniques. Some research has been done to improve LC-MS throughputs while maintaining 
reasonable peak capacity, including implementation of overlapping injections, multiplexing, and 
employing fast gradients;55–57 however, these techniques are not always applicable and still require 
tens of seconds to minutes per sample.  
Using CE with MS can overcome LC-MS limitations to some extent, using nanoliters of 
sample per injection and the ability to achieve faster separations.15,58 CE-MS also overcomes some 
of the selectivity limitations of LC-MS, specifically in that CE can efficiently separate the charged, 
polar compounds that RPLC inherently struggles with. CE-MS also offers the advantage of a 
variety of preconcentration techniques that can be applied to enhance detection sensitivity. 
Furthermore, microchip electrophoresis (MCE) has gained popularity due to its ability to achieve 
millisecond separations, high efficiency, and high throughput sample introduction.59,60 More 
recently, MCE has been paired with MS, presenting unique features including integrated ESI 
emitters, device arrays, on-chip sample preparation/treatment, high throughput sample 
introduction, and minimal sample volume requirements for CE-MS.61 
Though advances have been made to improve LC-MS and CE-MS throughputs, direct ESI-




separation prior to sample introduction. The perpetually increasing demand for improved 
throughputs by ESI-MS has lead to the development of many different commercialized and 
Figure 1-4: Comprehensive overview of high throughput sample introduction methods/instruments using ESI or alternative 
ionization techniques as of July 2018. Adapted from Kempa. et. al., 2019. *Droplet microfluidics for sample introduction has 






homebuilt autosamplers and other sample introduction systems (Figure 1-4). Commercialized 
systems such as the Agilent RapidFire have become popular as they can introduce samples at a 
rate of 7 s/sample, which includes the draw, spray, and rinse times while remaining automated. 
They often even incorporate automated SPE steps during the sample introduction, allowing for 
improved sensitivity and limits of detection for samples without manual sample preparation.62 
These systems are robust and easy to operate; however, they are extremely expensive and still on 
the scale of ~0.1 Hz or lower for sample introduction. 
 Alternative forms of ionization that function similarly to ESI have been used to improve 
throughputs for MS. Examples include desorption electrospray ionization (DESI) and acoustic 
mist ionization (Figure 1-4). DESI functions similarly to ESI, where it emits a stream of charged 
solvent from an emitter, though this stream is aimed at a sample/surface which then emits 
subsequent secondary ions for mass analysis. DESI has been applied for high throughput screening 
and has been shown to achieve up to nearly 3 Hz from a spotted plate.63 Acoustic mist ionization 
has also been used for HTS.64 This technique is performed from a well plate, where acoustic energy 
is used to emit a fine mist of charged, micrometer-sized droplets from the solution in each well 
which then enters the mass spectrometer. Sample introduction and analysis can be done rapidly 
and has been shown to achieve throughputs up to 3 Hz.  Though new techniques are constantly 
being developed, these are the most notable recently developed ionization techniques for use with 
high throughput screening (HTS) by MS.  
Recently, droplet microfluidics paired with ESI-MS has shown promise due to a variety of 
advantages, including the capability to achieve high throughput analysis. It has been shown that 
sample introduction rates up to 30 Hz can be achieved, which was achieved using a QTOF with 




resulting method had a relatively high standard deviation. Despite several limitations in this report, 




In microfluidics, devices and tubing 
with micron-width channels are 
implemented for the miniaturization of a 
variety of analytical and biological 
applications. These devices are useful due to 
their ability to rapidly manipulate small 
volumes of fluid (10-9 – 10-8 L), which can 
be used for studies on a cellular-sized scale, 
or even smaller.65 Microfluidic technology 
has been used for developments in 
pharmaceuticals, drug design, diagnostics, 
chemical synthesis, and high throughput 
screening, among other applications.66 
Droplet microfluidics is a subcategory of 
microfluidics that uses two immiscible phases flowing together within a microchannel.67 Droplet 
microfluidics can offer higher throughputs and manipulate smaller fluid volumes than traditional 
microfluidics. 
Droplets are generated, representing individual reaction vessels or samples, separated from 
one another by an immiscible “continuous” phase, such as air or fluorinated oil. Droplets range in 
Figure 1-5. Illustration of the common droplet microfluidic operations. Adapted from 




volume from single femtoliters to tens of nanoliters and offer many advantages including rapid 
mixing/mass transfer, short diffusion distance, extremely high throughputs/droplet generation 
rates, discrete samples/reaction vessels, and the ability to manipulate droplets and flow on-chip.67 
Microfluidic systems can be paired with many different analytical techniques,68,69 including 
various optical detectors, microscopy, and mass spectrometry, for rapid chemical analysis of 
discrete samples encapsulated in droplets.70  
Many microfluidic geometries allow for a variety of manipulations and operations to be 
performed on these droplets at high throughput (Figure 1-5).71 Droplet generation, a crucial aspect 
of droplet microfluidics, can be performed off-chip from a well plate or with an on-chip generator. 
Generating from a well plate has the advantage of easily profiling of a pre-prepared and large 
sample array. This mode is excellent for screening, as thousands of reactions can be run in parallel 
within well plates.72 The ability for tracking samples (droplets) in this mode drastically simplifies 
screening workflows compared to on-chip droplet generation, where screening libraries are 
generated stochastically.71 However, generation speed and quantity of tandem samples is limited 
in this mode due to vacuum-driven droplet formation and robotic handling. On the other hand, on-
chip generation, as shown in Figure 1-5A, can reach much higher droplet generation frequencies 
(kHz).73 Generating on-chip also facilitates droplet stabilization and storage for later use, as an 
abundance of droplets can be continuously generated and surfactant stabilized before being 
transferred to a storage vessel.74 
Reagent addition is another important unit operation in droplet microfluidics. The 
composition of each droplet can be altered by adding a different solution to each droplet. The most 
common methods for adding reagent are picoinjection/direct injection, to add solution directly 




can be performed at high throughputs (kHz) and offer high delivery volume precision.76 Reagent 
addition can be used to perform dilutions, adjust the solution/solvent composition, or add reaction 
substrates/components to droplets. Microfluidic systems will often have several reagent addition 
channels in a device (up to three), allowing for several manipulations to occur in a single 
workflow.79  
Other droplet microfluidic manipulations include droplet splitting and droplet sorting. 
These functions rely on features built into the microfluidic device that can be controlled via applied 
flow or voltage. Splitting allows for a single droplet to be split, where often one portion is placed 
in storage and the other is sent to the detector. Volumetric split ratio is controlled by the relative 
dimensions of the channels that the droplets are split into and their relative flow 
rate/backpressure.80 Droplet sorting allows droplets that meet certain specifications (i.e. presence 
or absence of a certain compound) to be sorted into a different channel than the others. This is 
typically done using a colorimetric or fluorescent indicator to select which droplets to sort.81 The 
droplets are sorted via electric field or magnetic field, where an activate field will allow droplets 
to be sorted into a different channel (Figure 1-5E).82,83 
 The rapid processing, efficient mixing, short diffusion distances, and low volume 
attributes of droplet microfluidics have made the technique viable for miniaturization and 
throughput improvements in analytical methods and bioassays.72 One example is the use of droplet 
microfluidics for liquid-liquid and solid-phase extractions. Liquid-liquid extraction techniques 
have been developed using extraction phase as the carrier fluid to allow for extractions to occur as 
the droplets flow, facilitated by rapid mass transfer.84–86 These systems have been used to study 
extraction dynamics and as an analytical tool for low-volume sample cleanup. Droplet microfluidic 




utilizing functionalized magnetic solid-phase particles, which can retain different target analytes 
depending on the type of functionalization.83,87,88 Several operations can be easily performed on 
the magnetic particles before and after retaining analytes, including dispersing, immobilizing, and 
washing of the particles.89 This allows for complete SPE procedures to be integrated into the 
droplet microfluidic system, with rapid and low-volume extractions. 
Droplet microfluidics has been used for the miniaturization of many other bioanalytical 
tools and bioassays as well. Some of the recent and notable adapted bioassays include RNA 
sequencing, directed enzyme evolution, cell profiling, and digital PCR.90–92 Droplet microfluidic 
platforms have been used to offer improvements in bioanalysis as well. This includes applications 
to biomarker discovery, small molecule detection, macromolecule analysis, single-cell analysis, 
high throughput screening, and even development of droplet-MS technology.72,93–95 Droplet-MS, 
the coupling of various droplet microfluidic platforms to mass spectrometry, has gained significant 
momentum over the past decade due to its high information content, label-free capabilities, and 
capacity for high throughput analysis. 
Droplet-Mass Spectrometry 
 
Laser-induced fluorescence is one of the most common detectors for droplet microfluidics 
due to its low LODs and fast acquisition rates, making it highly compatible with the low volumes 
Figure 1-6: Illustration of general droplet microfluidics being paired with ESI-MS. Specific labels provided for the different fluids present 




and high frequencies encountered in droplet microfluidics.71 However, LIF efficacy is dependent 
on fluorescent analytes, which requires naturally fluorescent compounds or a fluorescent labeling 
procedure before detection. Coupling MS detection to droplet microfluidics, though less sensitive 
and having slower acquisition speeds, can provide much more information per droplet than optical 
detectors and is a widely applicable, label-free detector.70 These advantages make droplet-MS 
much more suitable for analysis of complex mixtures and biological samples than droplet 
microfluidics paired with optical 
detection. 
 As shown in Figure 1-6, 
droplet microfluidics can be 
paired with ESI by simply 
attaching the line of flowing 
droplets to an ESI or nESI emitter. 
The applied electric field will 
spray and ionize the 
aqueous/sample droplets as they 
reach the emitter tip, but the 
electrospray will stop as the non-
conductive carrier fluid reaches 
the tip and temporarily breaks the 
ESI circuit. This process allows 
for rapid introduction of an array of droplet samples or a continuously generated flow of droplet 
samples by ESI without signal interference from the carrier fluid (Figure 1-7). As a “train” of 
Figure 1-7. (A) Resulting MS data corresponding to droplet-ESI-MS/MS of 
various concentrations of leucine-enkephalin. (B) Image of the ESI emitter at 
various times during droplet infusion (1. aqueous sample and 2. carrier phase at 




assorted droplets are sprayed, each will produce an individual and discrete MS signal for the ion(s) 
being monitored, and there will be no signal as the carrier phase reaches the tip.96  
Droplet microfluidics paired with MS was initially reported in early 2009, where droplets 
were generated on-chip and analyzed by MS.97 However, this method required removal of the 
carrier fluid before ESI by extraction of droplets into a continuous aqueous stream, compromising 
droplet discretization and causing sample dilution. Droplet microfluidics directly interfaced with 
MS was first reported in late 2009. Using an ion trap mass spectrometer, droplet-MS was able to 
achieve sample analysis rates of 0.8 Hz using 13 nL droplets (50:50 MeOH:H2O, v:v) and air as 
the carrier fluid. Detection limits down to 1 nM were achieved for the target analyte using MS3.96 
Since this initial report, many improvements have been made to direct droplet-MS. Droplet sizes 
have been reduced as low as 65 pL for infusion, with rates up to 10 Hz. In a similar experiment 
reproducible sample signal was obtained for over 2.5 hours (Figure 1-8).1 Sample analysis rates as 
high as 30 Hz have been reported.2 Employing nESI emitters, droplet-MS has been used to directly 
analyze complex biological samples obtaining low nM LODs for biological compounds, and many 
compounds have been monitored simultaneously in experiments.98 Droplet-MS has been used for 
a variety of applications, including high throughput screening, enzyme evolution, mass activated 
droplet sorting, neurochemical monitoring, and temporal resolution enhancement.1,23,24,98,99 
Figure 1-8. Droplet-MS data where a single mass transition is monitored for over 2.5 hr using 1.2 nL droplets. This accounted for over 20,000 individual 







Given the constantly evolving features and applications of electrospray ionization and the 
techniques that can be interfaced with it, the work in this dissertation aims to develop new systems 
and manipulate/improve current systems revolving around improving throughputs and LODs with 
ESI-MS/MS. Chapter 2 focuses on improving the sensitivity and LODs of CE-MS, a technique in 
constant competition with LC-MS. In this work, we develop a powerful preconcentration 
technique that has rarely been reported to be interfaced with MS to overcome the significant LOD 
limitation of CE-MS. The preconcentration technique, electrokinetic supercharging (EKS), is 
developed with an emphasis on MS compatibility. EKS is compared to other notable 
preconcentration techniques paired with MS, and some of the fundamental principles of EKS are 
investigated including injection limitations and formation of a reported but not well-studied 
system-induced terminating electrolyte. The developed method is then applied to determine 
several neurotransmitters from biological tissue samples. 
Chapter 3 improves upon an existing method that allows for the segmentation of 
microdialysate into ~5 nL fractions via droplet microfluidics for improvements to temporal 
resolution during neurochemical monitoring with MS/MS analysis. The initial reports using this 
method have several limitations, including a limited number of analytes monitored (up to 4) and 
insufficient LODs for many neurochemicals of interest. The work in Chapter 3 expands the range 
of the method, allowing for up to 7 neurochemicals (plus 7 internal standards) to be simultaneously 
monitored and the addition of important low abundance (low nM) neurotransmitter analytes 




changes in rodent brains in response to drug stimulations, and the temporal information is 
compared to that obtained by LC-MS/MS. 
Chapter 4 describes the development and characterization of a completely new method for 
rapid and low volume liquid-liquid extractions called slug flow nanoextraction (SFNE). SFNE is 
a multi-phase system developed utilizing the principles of droplet microfluidics to achieve rapid 
and in-line extractions while flowing through a capillary, where many extractions can occur 
simultaneously. SFNE was characterized by comparison to traditional extraction methods and 
previously reported equations to validate its performance. The developed method is applied to 
online sample cleanup for mass spectrometry. Here, the signal intensity by ESI-MS/MS with and 
without the use of SFNE is compared. SFNE was also applied for the determination of Kow values 
and compared to the shake-flask method for Kow determination.  
In Chapter 5, SFNE is re-formatted to allow for continuous, online generation, and 
automated sample introduction. In this work, a microfluidic device is designed and fabricated that 
allows for the constant generation of distinct “phase-pairs” as three distinct phases are flowed into 
the device. The performance of the device is evaluated including the ability to rapidly adjust 
volume ratios, generation frequency, and the number of phases being used. The automation of 
sample introduction is investigated and achieved through pairing with an LC autosampler allowing 
for injections every 78 s. Finally, this method was applied for the screening of Kow values for 
various compounds under different conditions from a well plate, screening 21 Kow values in under 
2 h. 
Previously, we have reported studies using droplet microfluidics paired with nESI to screen 
samples or reactions from well plates. In Chapter 6, this set-up is used to provide a sensitive and 




increase the biocatalytic activity of a cytochrome P450 for biaryl coupling, the enzyme is 
selectively evolved to generate thousands of different mutations. The droplet-MS/MS method 
being applied in this work is capable of screening hundreds of reactions per day, greatly reducing 
the time required for this step of the enzyme evolution processes. In this work, the method is 
optimized for a balance of low LODs (for low initial yield) and high throughput. The method is 





























CE-MS with Electrokinetic Supercharging and Application to Determination of 
Neurotransmitters 
Reproduced from Wells et al, Electrophoresis 2019, 40, 2946–2953. Copyright 2019 WILEY-VCH Verlag GmbH 




CE and CE-MS have become a popular technique for the analysis of complex biological 
samples due to its efficiency, small volumes, and separation speeds. However, hyphenation of CE 
with MS has been difficult to achieve due to complications interfacing via ESI. There have been a 
variety ESI interfaces developed for CE-MS, both homebuilt and commercial, that have opened 
CE-MS to application in many fields including proteomics,100 food science,101 drug analysis,102 
genomics,103 and more. CE-MS has more recently gained significant momentum in the fields of 
neuroscience and both target and untargeted metabolomics, as it can employ high efficiency 
separations from the limited volume often available for biological samples, and CE can often 
provide better separation for small, polar metabolites than RPLC.12,16 
 There are currently two types of common CE-MS interfaces, each with particular 
advantages.38 Sheathflow interfaces utilize coaxial conduits that introduce both solvent and gas 
flow along with the electrophoresis eluent to assist with ESI. The other common interface is 
sheathless, which can generate ESI or nESI directly from the separation capillary without assisted 
flows. Sheathless interfaces, as they offer zero dilution and can employ nESI, are often the most 
sensitive CE-MS interface; however, they can be more challenging to achieve and operate. One 




metabolites with LODs down to 60 nM. 104 Though a low nM LOD may be an achievement for 
CZE paired with MS, these are relatively high LODs compared to other separation and detection 
methods. This is due to the small injection volumes encountered in CE, limiting the detectable 
mass. To overcome this limitation, preconcentration methods are often implemented for improving 
detection limits and sensitivity by CE-MS.  
 As previously discussed, a variety of online preconcentration techniques have been 
developed to improve the often poor detection sensitivity encountered in with CE separations. 
Some of the more common preconcentration methods include FASS, FASI, tITP, pH-mediated 
stacking, LVSS, and sweeping, though many other methods exist.48,105 Each preconcentration 
technique functions based on different principles, however the general mechanism is the 
concentration of disperse analyte molecules into a low volume zone by manipulating an analytes 
mobility. Many of these techniques have been used with CE-MS including FASI, dynamic pH 
junction, LVSS, and others.106–109 Field amplification based preconcentration techniques are the 
most effective and simple methods for achieving high sensitivity.110 The primary focuses of field 
amplified stacking techniques are to achieve the minimum possible bandwidth and to inject the 
maximum amount of analyte. Since most field amplified stacking techniques implement both 
principles simultaneously, these techniques can drastically improve LODs and maintain or 
improve separation efficiency.  
Of the field amplification stacking techniques, EKS is the most powerful, having achieved 
over five orders of magnitude improve in detection sensitivity compared to a conventional 
injection.111 EKS can achieve such drastic improvements since it combines both FASI and tITP, 
allowing injections to overcome limits on FASI, where the separation will rapidly lose efficiency 




concentrated during electrophoresis, allowing for a much larger initial injection. Since its 2003 
introduction,112 EKS has been combined with UV absorbance detection for several high sensitivity 
applications, including measurements of rare earth metals, 113 environmental contaminants,114 
protein complexes,115 DNA,116 peptides,117 and drugs.118 EKS allows for these analytes to be 
measured in low abundances. 
EKS is achieved using the following steps as shown in Figure 2-1. First, a small plug of 
high ionic strength leading electrolyte is loaded into the separation capillary followed by a small 
plug of water which will act as the headspace. Next, a long and/or high electric field injection is 
performed. During this step, FASI occurs where the high mobility molecules preferentially migrate 
into the capillary. Once these molecules reach the LE boundary, they experience a significant 
decrease in mobility due to the lower electric field distributed across this higher ionic strength 
zone. This stacking principle allows for a long injection to take place before excessive band 
Figure 2-1: Illustration of the general scheme for EKS. Each of the steps are shown, where arrows indicate applied pressure for volume loading 




broadening occurs. Finally, a small plug of terminating electrolyte is loaded into the capillary and 
the separation voltage is applied for the remainder of the separation. Initially during this separation, 
tITP takes place. Due to the varying ionic strength and mobility of the LE and TE zones, the electric 
field is distributed as a gradient across the sample zone, allowing the analytes to further concentrate 
into discrete zones based on their respective electrophoretic mobilities. The presence of tITP 
allows for a longer FASI injection to occur, as the analytes zones will be further narrowed during 
this step. Eventually, the LE and TE will dissipate and CZE will occur for the remainder of the 
separation. To achieve the maximum amount of preconcentration, it is ideal to limit the movement 
of the LE stacking boundary during the injection step, which is commonly accomplished using 
counter-flow or environments for reduced EOF.113–116  
Despite its powerful preconcentration, EKS has almost no reported work being interfaced 
with CE-MS. This is due to several challenges specific to EKS with CE-MS, including buffer 
compatibility, controlling flow, and maintaining robust CE ground at the ESI interface. Many 
common CE buffers such as phosphates, TRIS, borates, etc., are incompatible with MS. Mass 
spectrometers with ESI require volatile and non-suppressing buffers, limiting the buffer options 
when selecting the BGE, LE, and TE. This limited selection can affect the method design when 
attempting to achieve compatible LE and ionic strength requirements for stacking. Furthermore, 
suppression of EOF and analyte migration is important for attaining high detection sensitivity and 
efficiency, though counter-flow cannot be easily implemented with MS detection due to the 
presence of the ESI interface, as it is often used for EKS with UV detection. This makes flow 
control and reduce migration largely dependent on the buffer composition. For example, lowering 
the pH of the buffer can drastically reduce or even remove the EOF of the system, allowing for a 




However, this will come at the cost of overall separation speed and/or efficiency. Finally, 
maintaining a robust ground to the CE circuit is imperative for the continuous operation of the 
system. Maintaining ground has proven challenging when interfacing to MS via ESI, especially 
when using a preconcentration technique like EKS which generates highly concentrated zones that 
can cause significant fluctuations in conductivity. While using sheathflow, the sheath liquid 
contacting the migrating CE fluid grounds the separations, however, these concentrated ion zones 
can interfere with that ground and the stability of the ESI. Proper and robust operation of this 
interface requires careful selection of the buffer system, sheath liquid composition, and CE and 
sheath flow rates, as well as reliable assembly of the interface. 
EKS with CE-ESI-MS was first reported in 2009,51 and has since been only reported once 
(excluding our study).119 In the original report, the method was able to achieve baseline resolution 
of five different hypolipidaemic drugs with 1000-fold-improvements in detection sensitivity 
compared to a “conventional” injection using FASS conditions. This was a novel report that 
pioneered the implementation of EKS preconcentration with CE-MS, showing that drastic LOD 
improvements can be obtained while having the unique benefits of MS detection; however, this 
method had several important limitations. This technique required regular disassembly of the CE-
MS interface for capillary treatments with EOF reversal agents as well as an applied pressure 
during separation to produce and maintain the reversed EOF system to analyze the desired anionic 
compounds. These steps, along with the selected buffer systems/flows, compromise the robustness, 
maximum throughput, maximum injection duration, and efficiency that can be achieved using this 
method. One other method has been reported, where HDI, FASI, and EKI were all applied to for 
the analysis and preconcentration of three hormone variants by CE-ESI-MS/MS using a sheathless 




µg/mL to pg/mL range while using EKS, offering significant improvements in limits of detection. 
This report shows how powerful EKS preconcentration paired with CE-MS can be, especially 
when using a sheathless interface. However, this method has several limitations due to its use of 
neutral capillary coatings and applied separation pressure, compromising efficiency, resolution, 
and throughput, as well as its minimal EKS method development. As a result, when EKS 
conditions are used, one of the three hormone variants is no longer detected and the two remaining 
analytes are no longer baseline resolved, resulting in a poor separation. 
In this work, we present a new method employing EKS with CE-ESI-MS/MS, as well as 
an investigation of the merit of a “system-induced” terminating electrolyte. This method provides 
an online system that uses a buffer system and pH allowing for a normal (cathodic) but highly 
suppressed EOF to allow for high sensitivity and efficiency without the use of capillary 
coatings/treatments and no necessary pretreatment of the aqueous samples as reported in previous 
studies. Omittance of any sample preparation and capillary pretreatment steps allow for a more 
robust system with potential for higher throughputs that is broadly applicable to positively charged 
compounds. The use of a highly suppressed EOF allows much longer FASI injections and therefore 
lower LODs. EKS preconcentration here allows for 5000-fold lower LODs compared to a 
conventional HDI injection by CZE. This method was able to obtain detection limits as low as 10 
pM in a 16-minute separation for seven different biogenic amine neurotransmitters. 
In this study, the method is applied to the determination of seven different 
neurotransmitters in multiple types of tissue extracts (Table 2-1). Though EKS for determination 
of neurotransmitters has been previously reported,120,121 these methods have utilized techniques 
(i.e. counterflow) and buffer systems to achieve sufficient LODs that are incompatible with ESI-











Choline Ch 104.17 n/a 
 
104  →  60 
Tyramine TyrA 137.18 9.66 
 
138  →  121 
Octopamine OA 153.18 8.98 
 
136  →  119 
Dopamine DA 153.18 9.27 
 
154  →  137 
Serotonin 5HT 176.22 10.00 
 
160  →  115 
Norepinephrine NE 169.18 8.85 
 
152  →  107 
Epinephrine EPI 183.20 8.91 
 
166  →  107 
Table 2-1: List of all compounds for which the EKS with CE-ESI-MS/MS method was developed. Molecular 
weight, pKa, structure and most sensitive mass transition listed for each compound. 
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techniques have limited selectivity and specificity, and are limited in the number of 
neurotransmitters that can be simultaneously determined (three). Studying changes in the 
composition and distribution of neurochemical in the brain can lead to a better understanding of 
various behaviors and disease states. Measuring neurochemicals from tissues samples using our 
method will demonstrate the utility and power of the method to quantify various low concentration 
compounds from low volume samples. 
Materials and Methods 
 
  Reagents and Materials. All chemicals and solvents were purchased from Sigma-
Aldrich (St. Louis, MO, USA) unless stated otherwise. Formic acid (99%) was from Acros 
Organics (Geel, Belgium). Stable-isotope labeled internal standards were purchased from CDN 
Isotopes (Quebec, Canada). Neurotransmitter standards and internal standards were prepared in 
HPLC-grade water as 100 µM and 100 nM stocks (respectively), aliquoted, and stored at -80 ⁰C. 
The standard and internal standard aliquots were thawed daily (single use) and diluted for use. 
Standard mixes consisted of the seven neurotransmitters of interest and internal standard mixes of 
deuterated versions of the compounds of interest, excluding tyramine and octopamine. BGE 
contained 50 mM ammonium formate (pH 2.5) and 40% MeOH (v/v) and LE contained 250 mM 
ammonium formate (pH 2.5). Buffers were prepared fresh twice weekly, adjusting the pH by 
formic acid, sonicating for 10 min, and filtering through 0.45 µm membrane filter. Sheath-flow 
buffer contained 5 mM ammonium formate and 50% MeOH (v/v).  
Instrumentation. Electrophoretic separations were performed on an Agilent 7100 
Capillary Electrophoresis System using Agilent Masshunter software for CE-MS and Agilent 
ChemStation software for CE-UV. Electrophoresis experiments were performed in 80 cm of 50 




polyimide from Polymicro Technologies (Phoenix, AZ, USA). New capillaries were treated by 
flushing the capillary with 1 M NaOH for 20 min, HPLC-grade water for 5 min, and BGE for 10 
min. ESI was carried out using an Agilent CE ESI-MS Sprayer and an Agilent 1260 Infinity 
Isocratic Pump to control the sheath-flow. MS detection was performed on an Agilent 6410 Triple 
Quadrupole, using Agilent Masshunter software. 
Injections and Preconcentration. HDI. The capillary was filled with BGE. A short plug 
of HPLC-grade water was introduced at the inlet at 50 mbar for 1 s. Sample was injected at 50 
mbar for 65 s to fill 5% of the capillary volume. A separation of 30 kV was applied. EKS. The 
capillary was filled with BGE, and a plug of LE was injected at 50 mbar for 30 s. A plug of HPLC-
Grade water was hydrodynamically introduced at the inlet at 50 mbar for 1 s. Sample was then 
injected electrokinetically at 30 kV (375 V cm-1) for 150 s. A separation voltage of 30 kV was 
applied. FASI. The capillary was filled with BGE. A short plug of HPLC-Grade water was 
hydrodynamically introduced at the inlet at 50 mbar for 1 s. Sample was then injected 
electrokinetically at 30 kV (375 V cm-1) for 30 s, (injections ranged from 5 – 50 s for comparisons). 
A separation voltage of 30 kV was applied. FASS. The capillary was filled with BGE. A short 
plug of HPLC-Grade water was hydrodynamically introduced at the inlet at 50 mbar for 1 s. 
Sample was then injected hydrodynamically at 50 mbar for 195 s to fill 15% of the capillary 
volume (injections filling 5 – 25% capillary volume tested for comparisons). A separation voltage 
of 30 kV (375 V cm-1) was applied. 
ESI-MS. For ESI, sheath liquid flow rate was set to 10 µL min-1 and nebulizer gas flow at 
12 psi. Drying gas was used to assist with desolvation with a flow rate of 8 L min-1 at 300 C. The 
electrospray potential was set to 4 kV. For MS, single reaction monitoring (SRM) mode was used 




quadrupole three for each compound (Table 1-1) and collision energies were optimized to produce 
the highest abundance of each product ion with dwell times of 200 ms. The source and drying gas 
temperature was 250 ⁰C. 
Sample Preparation. Rat Brain Stem. Homogenate was prepared from a whole rat brain 
stored at -80 ⁰C. After thawing, the brain stem was sliced off and homogenized using a pestle 
homogenizer in a vial with cold ACN (10 µL mg-1). The homogenate was centrifuged 13 x 103 x 
g for 5 min, and the supernatant was collected. The supernatant was dried with nitrogen and 
resuspended in water (10x original volume). The sample was then aliquoted (100 µL aliquots) into 
vials which were subsequently frozen and stored at -80 ⁰C until analysis. After thawing, 1% 
internal standard (v/v) was added prior to analysis. Whole Fly. Homogenate was prepared by 
homogenizing 10 whole Drosophila (male) in 150 µL of cold ACN, centrifuging, and removing 
the supernatant. Aliquots were stored at -80 ⁰C until day of analysis. After thawing, 1% internal 
standard (v/v) was added and they were dried with nitrogen and resuspended in water (same 
volume) for immediate analysis.  
LC-MS/MS Analysis. Chromatographic separations were conducted using a Waters 
nanoAcquity UPLC using a 1.0 x 100 mm column with HSS T3 1.8 µm particles interfaced to a 
mass spectrometer. Mobile phase A and B consisted of 5 mM ammonium formate with 0.15% 
formic acid and neat ACN, respectively. The gradient ran from 5% to 19% B in 0.01 min, 19% to 
26% in 0.67 min, 26% to 75% B in 0.375 min, 75% to 100% B in 0.75 min, and stayed at 100% B 
for 0.1 min. The flow rate was set at 0.6 mL min-1. 
For LC-MS analysis of the brain stem homogenate supernatant (as prepared above, 
excluding internal standard addition), a benzoylation reaction was implemented. Derivatization 




carbonate to raise the pH. Then 1 volume of 2% (v/v) benzoyl chloride in ACN was added followed 
by 1 volume of internal standard in 1% sulfuric acid (v/v) in 20/80 MeOH/water. The resulting 
mixture was analyzed by LC-MS. The internal standard mixture is comprised of analyte standards 
derivatized with the same procedure using C13 benzoyl chloride as the derivatizing agent. 
Results and Discussion 
 
Buffer Selection. Initial experiments for method development were performed using EKS 
with CE-UV and a smaller subset of our test compounds which included DA, NE, EPI, and 5HT. 
Experiments for buffer selection revolved around low pH and MS compatible electrophoresis 
buffers that would both facilitate ionization when paired with ESI and suppress EOF for 
preconcentration.122 EOF suppression is imperative for the EKS method developed to allow for a 
long electrokinetic injection without excessive migration of the stacking boundary or analytes 
down the capillary. Excessive migration during injection would lead to limited resolving power 
and lower separation efficiency for positively charged/higher mobility analytes. Twenty 
millimolar ammonium formate at a pH of 2.5 was initially selected due to its low pH buffer 
capacity and volatility for ESI compatibility. This initial selection did not allow for baseline 
resolution of all four compounds. To further suppress EOF and improve selectivity in the 
separation, methanol was added to the separation buffer and the ammonium formate concentration 
of this solution was increased to 50 mM to maintain the initially sought conductivity in the new 
buffer solution (Figure 2-2A). The final buffer consisted of 50 mM ammonium formate in 
water/MeOH (60:40, v/v) with pH 2.5 and provides resolution for all four compounds. The chosen 
buffer offers a highly suppressed EOF to allow for longer electrokinetic injections for 




Selecting and implementing a 
LE and TE will provide conditions 
for EKS to occur, allowing for much 
longer injections. LE buffer was 
chosen by testing electrolytes sodium 
chloride and ammonium formate 
with 15 s electrokinetic injections 
(Figure 2-2B). Two hundred and fifty 
millimolar ammonium formate at pH 
2.5 showed the best performance as a 
LE, with nearly double the peak 
signal of 100 mM NaCl (similar 
conductivity). On top of offering 
stronger signal improvement, 
ammonium formate is a more 
compatible electrolyte for use with MS due to its volatility. To load the LE, 50 mbar is applied for 
30 s to fill 2.3% of the capillary volume. This volume allows for a sufficient LE zone while having 
a negligible effect on overall separation current. 
FASI Investigation. To determine the limitations of FASI, this preconcentration method 
was investigated with varying injection durations. FASI conditions can be met using the previously 
described buffer with extended electrokinetic injections and no leading electrolyte. Three different 
injection durations were tested including 10 s, 30 s, and 50 s injections to monitor and understand 
the changes in peak shape, peak height, and resolution between adjacent peaks as the injection 
Figure 2-2: (A) Electropherograms of the different buffer systems tested for 
obtaining sufficient selectivity and resolution for 4 test compounds in a 20 kV 60 
cm separation using CE-UV with HDI injections. (B) Comparison of two potential 
LE candidates using EKI in a 20 kV 60 cm separation. 
Figure 129 2-2: Investigati n f electrolyte system 
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conditions are varied. After increasing 
past 10 s of EKI, both peak tailing and 
peak broadening become apparent. 
Under these conditions, FASI is limited 
to < 30 s before peak broadening and 
peak tailing become detrimental and 
affect resolution (Figure 2-3). Utilizing 
EKS conditions will allow for longer 
FASI injections to occur without losing 
efficiency and without causing peak tailing as 
seen in Figure 2-3. 
Terminating Electrolyte. Initially, 5 mM 
taurine was tested as the TE for tITP. The solution 
was loaded by applying 50 mbar for 10 sec after 
loading the LE and performing a 15 sec 30 kV 
injection of standards. As predicted, the use of the 
TE for tITP (and overall EKS) provided improved 
peak intensity and efficiency compared to the 
same injection and separation without the TE 
(Figure 2-4A), showing the activation of tITP and 
EKS conditions by presenting a TE. In this 
example, the peak width of DA was reduced from 
10.4 s to 5.4 s with 5 mM taurine as the terminator. 
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Figure 2-3: FASI injections performed at varying injection durations and the 
subsequent resolution changes between NE and EPI (100 nM). Injections 
performed at 30 kV in an 80 cm separation capillary. Resolution calculated 
using equation R = (tr2-tr1)/0.5(wB1 + wB2) 
Figure 2-4: (A) Comparison of a 15 s 30 kV injection using LE with and 
without 5 mM taurine as TE. (B) Comparison of varying EKS injection 
durations without the intentional loading of a TE. Results suggest 




Interestingly, it was observed that at longer injections if a TE was omitted, peak width and 
height were not adversely affected (Figure 2-4B), and intentional loading of the TE offered no 
improvements. At lower injection durations (15 s, 30 s) under the same conditions, resolution and 
efficiency were significantly worse without the presence of a loaded TE. However, as injection 
duration is increased, peaks heighten and narrow. We hypothesize this result is due to the formation 
of a system-induced terminating electrolyte.113 System-induced terminator formation is a 
previously reported phenomenon which results in tITP behavior without the loading of a dedicated 
terminating electrolyte as seen 
here.123,124 Based on these results, the 
final injection parameters were set to 30 
kV for 150 s, followed by a 30 kV 
separation voltage in an 80 cm capillary. 
This method was tested on seven 
analytes. Applying the selected LE and 
TE parameters determined above, five 
of the seven analytes could be baseline 
resolve within a 16-min separation with 
LODs down 10 pM (DA) using MS 
detection (Figure 2-5).  
Preconcentration Method Comparison. To determine the effectiveness and 
improvement offered by EKS, the developed method was compared to conventional HDI, FASS, 
and FASI under similar separation conditions (Table 2-2, EKS LOD reported here is improved 
from the EKS LOD reported in Table 3 due to adjusted MS/MS scan rates. DA LOD is the 




















Figure 2-5: Extracted ion electropherograms (MS/MS) from a separation of 1 
nM standards in water (Ch scaled down by a factor of 250 for scaling). OA 
and DA are isobaric compounds but are distinguished by MS/MS. 




exemplary LOD reported for all 
methods). HDI is the most 
common form of sample loading 
used in CZE. It is useful for 
injecting all compounds in an 
unbiased fashion, which cannot 
always be accomplished when 
using forms of EKI, although it 
injects a much lower mass of 
analyte than EKI. With HDI the 
maximum injection volume is 
generally limited to 5% of the 
capillary volume before peak 
broadening becomes detrimental 
to separation efficiency.125 
Comparing EKS with the 
alternative methods, we see a 
5000-fold enhancement using 
EKS over HDI, and nearly an 
order of magnitude enhancement 
over the next strongest mode of 
preconcentration, FASI. In 
addition to providing the lowest 
Table 2-2: EKS compared to other common forms of injection and preconcentration. 
LODs, resolution, and peak width are compared for each method, where enhancement 
factor is a quotient of the methods LOD over the HDI LOD. Resolution calculated 
using previously listed equation between NE and EPI. FWHM used DA peak width. 
Table 17-2: Comparison of CE-MS preconcentration methods 
Figure 2-6. Total ion electropherogram of four different injection/preconcentration 
techniques at concentrations that fit within each methods LDR. A subset of 3 
compounds used for this comparison including DA, NE, and EPI. These results are 
characterized in Table 2-2. 
Figure 193 2-6: Comparisons of different modes of preconcentration 
Table 2-3: Characterization of the calibration curves used for quantification of 










Choline 10.8 50 20 – 20,000 0.9994 
Tyramine 13.7 60 0.1 - 100 0.9926 
Octopamine 14.5 90 0.1 - 100 0.9997 
Dopamine 14.5 50 0.1 - 100 0.9996 
Serotonin 14.6 30 0.1 - 100 0.9977 
Norepinephrine 15.2 140 0.5 - 100 0.9916 





LOD of all the methods, EKS not only 
maintains, but decreases the peak 
width compared to HDI and 
maintains resolution greater than one, 
unlike the other preconcentration 
methods tested here. Additionally, 
EKS maintains relatively Gaussian 
peak shape while FASI and FASS 
display the effects of broadening and 
peak tailing, which can be detrimental 
to a separations efficiency and 
resolution Figure 2-6). 
Application to Biological 
Samples. Calibration curves were 
obtained for each compound in order 
to proceed with quantitation of 
biological samples and determine the 
quantification capabilities of the 
developed method, where the results 
of each calibration curve (used for rat 
brain stem homogenate) can be seen 
in Table 2-3. The LODs achieved for 
each compound make this method 
Figure 2-7: (A) Concentrations determined in rat brain stem homogenate by EKS with 
CE-MS/MS (black bars) and validation by LC-MS/MS (grey bars). EKS injections 
used 100 µL of sample and LC injections used 5 µL of sample per injection. Different 
aliquots of the same of the same supernatant used for each injection (triplicate by each 
method). (B) Extracted electropherograms for each compound in the rat brain stem 




potentially suitable for detecting and quantifying trace neurotransmitters. Calibration curves 
showed linearity (R2 = 0.99) from 0.1 – 100 nM for most compounds with LODs ranging from 30 
– 140 pM during biological sample quantification. To demonstrate the utility of this method to 
determine these neurochemicals from tissue samples, the method was applied to rat brain tissue 
and whole Drosophila tissue. Supernatant from a rat brain stem homogenate was analyzed and all 
seven neurochemicals in the method were quantified from triplicate injections (Figure 2-7). To 
successfully determine these chemicals, a ten-fold dilution of the supernatant in water was 
necessary to avoid the negative effects of the sample matrix on the stacking. Figure 2-7A shows 
the concentrations after accounting for the tenfold dilution, reflecting the original concentrations 
in the tissue extract determined by our method. In Figure 2-7B, each trace shows the detection of 
one of the seven analytes from the brain tissue. Choline overloads and interacts with capillary 
surface at high concentrations resulting in poor peak shape; however, this effect did not affect 
linearity of calibration. 
Supernatant of whole Drosophila homogenate was also analyzed to measure the 
neurotransmitters in a sample that 
contains lower concentrations. Figure 
2-8 shows the four neurochemicals and 
their concentrations in the supernatant. 
The concentrations correspond to an 
average of 0.17, 26, 0.010, and 0.046 
pmol/fly of DA, Ch, octopamine (OA), 
and 5HT, respectively. All seven 
analytes could not be detected as Figure 2-8: Graph of the determined concentrations from whole Drosophila tissue 




epinephrine and NE are not present in flies, and tyramine was below the LOD in this analysis. In 
this tissue, Ch, DA, 5HT, and OA were able to be quantified with good repeatability, with RSD 
ranging from 4.8–17.3%. In this analysis, the method demonstrated its ability to simultaneously 
measure pM (OA) and µM (Ch) concentrations, as well as the range between.  
LC-MS Method Validation. To verify the concentrations quantified by the EKS method, 
the same rat brain homogenate supernatant was analyzed using a published LC-MS/MS method.126 
Shown in Figure 2-7A, the concentrations determined by LC-MS/MS were comparable to the 
values determined by EKS, where concentrations determined differed by 14% – 46% between the 
two methods. Catecholamines DA, Epi, and NE differed between the two methods by 37%, 40% 
and -20% respectively. Catecholamine analogues TyrA and OA differed by 44 and -45% 
respectively and indolamine 5HT by 45%. Ch differed by 14%. Choline, the only compound 
without oxidizable moieties, had the most similar measured concentration between the methods.  
A possible source of the difference in results between CE-MS and LC-MS methods is 
sample stability.127 For CE-MS, samples were kept at room temperature for ~4 h before analysis. 
In contrast, for LC-MS samples were derivatized immediately before analysis. Derivatization has 
previously been shown to stabilize many of the oxidation prone neurotransmitters such as 
catecholamines and indoleamines.46,126 All compounds but OA and NE were measured to be higher 
concentrations by LC-MS, and OA and NE are within error of concentrations determined by each 
method. To test if sample stability contributes to error between methods, rat brain homogenate 
supernatant was analyzed by LC-MS after sitting at room temperature for up to 4 h before 
derivatization (Figure 2-9). DA, NE, Epi, and 5HT saw loss of concentrations by 20%, 11%, 24%, 
and 3.5%, respectively between 0 hours (n = 5) and 4 hours (n = 4). This loss of concentration for 




Other potential sources of error include differences in the sample treatment and separation 
parameters for each method. These results suggest that more rapid analysis or more care taken in 
preventing oxidation may be important in increasing the accuracy of the CE-MS method. Though 
all sources of the differences between these two methods is not completely understood, this 
comparison proves the utility of the presented method, showing comparable accuracy to existing 
methods. Being a CE-based method, this can inject from and use less sample volume than LC-
based methods, making it advantageous for low sample volume situations. This EKS method can 
also provide complimentary information that cannot be obtained by LC-MS, due to its 
orthogonality as a separation method, i.e. resolution of isomers OA and DA (Figure 2-7B). 
Conclusions 
 
A sensitive EKS method has been developed that can successfully interface to CE-MS 
using ESI and tandem mass spectrometry. This method overcomes many challenges and previous 
limitations of pairing this method of preconcentration to MS through careful selection of buffer 
systems and positively charged analytes that can be analyzed by the method. The method 
Figure 2-9: To test sample stability at room temperature, rat brain homogenate supernatant was analyzed by LC-MS after 0 and 4 hours at 
room temperature before derivatization. 6 analytes were measured, including Ch, TyrA, DA, NE, Epi, and 5HT. Ch (as expected) and TyrA 
showed no significant loss in concentration over the time period. DA, NE, Epi, and 5HT saw loss of concentrations by 20.5%, 10.6%, 24%, 




devlopment here has allowed for long and sensitive injections to take place for determining low 
abundance analytes without the use of sample pretreatments or capillary coatings as previously 
reported. LODs in this system are sufficient to analyze small molecules in many different samples, 
with detection limits down to 10 pM concentrations from standards, showing 5000-fold 
enhancements in detection sensitivity over conventional hydrodynamicinjections. 
 Additionally, in this work we performed experiments that provided a validation and deeper 
understanding of the formation of system-induced terminating electrolytes. Though this 
phenomenon is still not completely understood, previous studies have simply reported EKS or ITP 
systems as having formed these terminators without providing data demonstrating their presence 
and effectiveness as we have here. 
This method has been applied to biogenic amine neurotransmitters from tissue samples. In 
principle the method could be applied to other tissues. Improvements in protection against 
oxidation would be required for better accuracy. Samples containing high ionic strength matrices 
such as microdialysate and plasma can also be measured in this method, however they would 
require a pretreatment to remove or exchange the sample matrix prior to EKS. In theory, the 
enhancement by preconcentration that has been achieved through this method should make many 
complex samples analyzable by simply diluting them and maintaining sufficient sensitivty to 
detect these further diluted compounds. In future work, this method could be combined with MS 
through a sheathless nESI to offer further improvements to detection sensitivity and be further 










Droplet-nESI-MS/MS with Microdialysis for Sensitive and High Temporal Resolution 




Monitoring neurochemical concentrations and dynamics in the brain is imperative in 
neuroscience. This process can elucidate how the brain responds physiologically to specific disease 
states, behaviors, and various drugs.126 Recent examples of physiological studies employing 
neurochemical monitoring include amphetamine (AMPH) maintenance effects on DA and 5HT,128 
neurochemical changes due to traumatic brain injury,129,130 and neurochemical profiles in 
amyotrophic lateral sclerosis.131 Monitoring neurochemical dynamics is typically accomplished 
through the use of microsensors132 or sampling techniques such as microdialysis133 (MD) or push-
pull probes134 paired with an analytical instrument such as mass spectrometry (MS) for analysis. 
Microdialysis probes operate by sampling from the extracellular space in brain tissue, 
where the tip of the probe is comprised of a semipermeable, low molecular weight cutoff 
membrane. As artificial cerebral spinal fluid (aCSF) is perfused through the probe (0.1 – 3.0 
µL/min), salts and small molecules diffuse across the membrane from the extracellular space, and 
the perfusate can be collected and analyzed.133 MD is largely accepted and respected as a robust 
technique in neuroscience. It is often preferred over push-pull perfusion for sampling due to its 
ease of operation, preservation of anatomical and function integrity of the tissue, and generation 




Microsensors are another common tool used for neurochemical monitoring. Their small 
size and rapid scan speeds (ms range) allow for unmatched spatial resolution and temporal 
resolution. Despite these strong advantages, microsensors are typically limited to monitoring one 
neurochemical at a time, and analyte selectivity and specificity can be difficult to achieve.136 
Arrays of microsensors can be employed to achieve a broader range of neurochemicals that can be 
simultaneously monitored, though this can reduce the achievable spatial resolution.132 
Microdialysis, on the other hand, functions as a sampling tool rather than a mode of monitoring, 
presenting unique circumstances for MD as a tool for neurochemical monitoring. Though the 
spatial resolution is directly related to the size of the probe/membrane, temporal resolution and 
neurochemical range associated with MD are dependent on the perfusion flow rate, fraction size, 
and instrumentation used to analyze each fraction. 
High performance liquid chromatography paired with mass spectrometry (LC-MS) is the 
most common method for analyzing microdialysate fractions due to its sensitivity, selectivity, 
specificity, and potential to simultaneously determine many neurochemicals. LC-MS methods in 
neurochemical monitoring have shown simultaneous measurement of up to 70 different 
neurochemicals.46,137 Though regarded as the gold standard for analyzing microdialysate, LC-MS 
has some key limitations. Due to the volume requirements of HPLC (1 – 5 µL/injection) and typical 
perfusion flow rates in MD (1 µL/min), LC-MS is typically restricted to temporal resolution on a 
minute time scale (5 – 20 min), making LC-MS unsuitable for monitoring rapid concentration 
fluctuations and short-term neurochemical dynamics. These characteristics make LC-MS most 
suitable for monitoring long-term pharmacological effect, but make applications such as 




Many studies have focused on improving the temporal resolution of MD neurochemical 
monitoring that can be achieved by LC-MS, or through implementation of an alternative separation 
technique such as capillary electrophoresis (CE).134 Recent advances allow for temporal resolution 
on a second to low-minute time scale. For example, in 2018, Wilson et. al. demonstrated one-
minute temporal resolution while monitoring DA from rat brain microdialysate. In this study, DA 
concentration changes were induced through the administration of either high potassium aCSF or 
nomifensine and monitored via online LC-MS/MS.139 CE is another viable option for 
neurochemical monitoring due to several advantages such as low volume requirements (< 1 µL), 
high separation efficiency, and the ability to perform online preconcentration of analytes.140 In one 
example, Hogerton and Bowser demonstrated 20 s temporal resolution for up to 15 different 
neurochemicals simultaneously while using MD paired with online, ultrafast CE.141 However, 
despite various CE methods allowing for significantly improved temporal resolution with MD, CE 
has a major limitation in detection sensitivity with most detectors such (i.e. UV, MS), limiting 
potential analytes to high abundance neurochemicals. 
A less common approach for overcoming temporal resolution limitations in both MD and 
push-pull perfusion probes is the implementation of segmented flow. In segmented flow, small 
volumes (pL – nL) of aqueous sample are segmented by an immiscible, inert carrier fluid, which 
compartmentalizes the contents of each aqueous droplet and maintains temporal resolution. This 
approach was first demonstrated in 2008 when Wang et. al. segmented exiting perfusate into 6 – 
28 nL droplets in a microfluidic device using an inert carrier fluid and achieved temporal resolution 
as good as 15 s.142 Without the implementation of segmented flow, the same system demonstrated 
a temporal resolution ranging from 25 – 160 s. This was applied for monitoring glucose and its 




reported in other studies using MD and push-pull perfusion probes. In 2012, MD with segmented 
flow was implemented to achieve 5 s temporal resolution and 5 nM limits of detection (LOD) for 
the neurotransmitter ACh using direct ESI-MS/MS for analysis of the droplet fractions.24 
Similarly, in a study using microfabricated push-pull sampling probes, perfusate was segmented 
and analyzed by nESI-MS/MS with temporal resolution of 6 s for four different neurochemicals 
simultaneously, demonstrating the ability to monitor several compounds simultaneously using 
direct MS/MS.98 Finally, a recent study used a similar approach, where 50 s temporal resolution 
was achieved for Zn and Cu by segmenting perfusate from a push-push sampling probe, where 
droplets were analyzed by laser ablation – inductively coupled plasma – mass spectrometry.143 
Though these methods report drastically improved temporal resolution compared to other modes 
of microdialysate analysis, they are limited in the number of neurochemicals that are 
simultaneously monitored from each fraction, an important feature that makes MD sampling 
appealing. 
In this study, we present a method that achieves high temporal resolution neurochemical 
monitoring with MD that allows for simultaneous monitoring of seven different neurochemicals 
(ACh, DA, 5HT, GABA, Glu, Ado, Gln), several of which are low abundance neurotransmitters. 
Here, MD sampling probes are paired with segmented flow via a 50 µm inner diameter (i.d.) 
microfluidic cross junction to generate dialysis fractions averaging 5.3 nL (0.64 Hz) allowing for 
temporal resolution of 10.7 seconds. At the cross, internal standards (IS) and diluent are added to 
the dialysate as it segments. Droplet trains containing over 1,000 dialysate fractions are generated 
at the probe outlet and subsequently analyzed using a highly sensitive, low flow nESI-MS/MS 
method. The droplet-nESI-MS/MS method is optimized to achieve LODs for each of the targeted 




infusion flow rate, spray tip diameter, MS/MS scan speeds, assisting gas flow rates, aCSF 
composition, diluent composition, and dilution factor were assessed during method development. 
This method is compared to a conventional LC-MS/MS with temporal resolution of 5 min, and the 
in vivo monitoring dynamics are compared between the two methods. The utility of the droplet 
fraction method is demonstrated by monitoring dynamics of the seven neurotransmitters in 
response to brief administration of high potassium/low sodium aCSF. Additionally, to demonstrate 
the selectivity of the method, we monitored the neurochemicals as AMPH was directly 
administered to the probe site over a brief period of 30 s, which allows for selective stimulation of 
DA release and reuptake inhibition.144 
Materials and Methods 
 
Reagents and Materials. All Chemicals and solvents were purchased from Sigma-Aldrich 
(St. Louis, MO) unless stated otherwise. Perfluorodecalin (PFD) was purchased from Oakwood 
Chemical (Colombia Hwy, Estill, SC, USA). Isotopically labeled internal standards (d6GABA, 
Compound Precursor 
(m/z) 








GABA 104 87 0.15 10 200 10 
d6GABA 110 93 0.03 12   
AMPH 136.1 119.1 0.03 15   
ACh 146 87 0.1 17 100 5 
Gln 147 84 0.03 15 100,000 5,000 
Glu 148 130 0.1 8 600 30 
d4ACh 150 91.1 0.03 17   
d5Gln 152 135 0.04 10   
13C5Glu 153 135 0.04 10   
DA 154 137 0.15 13 100 5 
d4DA 158 141 0.05 13   
5HT 177 160.1 0.15 12 100 5 
d45HT 181 164 0.03 15   
Ado 268 136.1 0.05 18 200 10 
d1Ado 269 137 0.04 18   
Table 3-1: List of transitions, dwell times, and collision voltages for MS/MS  
Table 49 3-1: List of transitions, dwell times, and collision voltages for MS/MS analysis 
analysis  
 
Figure 3-1.(Top Left) MS/MS trace of the calibration curve for ACh with 5 droplets for each of the 6 calibration levels. (All other graphs) 
Average signal intensity vs. concentration to generate a 6 point calibration curve with error bars for each of the target neurochemicals. These are 
the curves used for quantitation during one day of in vivo experiments (09/21/20). LOD is calculated using the limit of the blank method.237 
Figure 257 3-1: Calibration curves and figures of merit used in neurochemical monitoringTable 3-1: List of transitions, 
dwell times, and collision voltages for MS/MS  
Table 50 3-1: List of transitions, dwell times, and collision voltages for MS/MS analysis 
analysis  
 
Figure 3-1.(Top Left) MS/MS trace of the calibration curve for ACh with 5 droplets for each of the 6 calibration levels. (All other graphs) 
Average signal intensity vs. concentration to generate a 6 point calibration curve with error bars for each of the target neurochemicals. These are 
the curves used for quantitation during one day of in vivo experiments ( 9/21/20). LOD is calculated using the limit of the blank method.237 
Figure 258 3-1: Calibration curves and figures of merit used in neurochemical monitoring 
 
 
Figure 3-1.(Top Left) MS/MS trace of the calibration curve for ACh with 5 droplets for each of the 6 calibration levels. (All other graphs) 
Average signal intensity vs. concentration to generate a 6 point calibration curve with error bars for each of the target neurochemicals. These are 




d4ACh, d5Gln, 13C5Glu, d4DA, d45HT, d1Ado) were purchased from CDN Isotopes (Quebec, 
Canada). For tuning and optimization, neurochemical standards and internal standards were 
prepared in HPLC-grade water as 100 µM stocks, aliquoted, stored at -80 ⁰C, and thawed for use 
daily as needed (single use). For quantitative calibration curve standards, mixtures of all 7 
standards were prepared in HPLC-grade water at 10 times the high point of the calibration curve 
(Table 3-1), aliquoted, stored at -80 ⁰C, and thawed for use daily as needed (single use). Mixtures 
of 200 nM internal standards were prepared in HPLC-grade water with 0.2% concentrated acetic 
acid, aliquoted, stored at -80 ⁰C, and thawed for use daily as needed (single use). aCSF was  
prepared in 500 mL of water with 145 mM NaCl, 2.68 mM KCl, 1.4 mM CaCl2 • 2H2O, 1.01 mM 
MgSO4 • 7H2O, 1.55 mM Na2HPO4, and 0.45 mM NaH2PO4 • H2O at pH 7.4. No phosphate (PO4) 
aCSF was prepared in 500 mL of water with 145 mM NaCl, 2.68 mM KCl, 1.4 mM CaCl2 • 2H2O, 
and 1.01 mM MgSO4 • 7H2O at pH 7.4. To mimic post-perfusion dialysate in standards, 
conventional aCSF and no PO4 aCSF were mixed 1:2 (33% PO4 aCSF). High potassium aCSF 
(100 mM KCl) was prepared in 250 mL of water with 47.68 mM NaCl, 100 mM KCl, 1.4 mM 
CaCl2 • 2H2O, and 1.01 mM MgSO4 • 7H2O at pH 7.4. D-amphetamine hemisulfate was prepared 
in aCSF to a final concentration of 100 μM. 
Well-Plate Droplet Generation and Transfer. Hamilton (Reno, Nevada, USA) gastight 
syringes were used (25 µL, 100 µL, 1 mL) with Chemyx Inc. Fusion 400 syringe pumps for 
infusion. For well plate droplet generation, a Harvard Apparatus PHD 2000 programmable syringe 
pump was used. Droplets were generated using a syringe pump drawing at a rate of 700 nL/min 
using a 25 µL syringe with a 20-30 cm length of 150 µm i.d. by 360 µm outer diameter (o.d.) PFA 
tubing from IDEX (Lake Forest, Illinois, USA). Connections were made using low dead volume 




an XYZ-position manipulator to draw from a 384-microwell plate, where a layer of PFD carrier 
fluid is deposited on top of aqueous samples, and droplets are generated as the tubing is moved 
between the two layers while vacuum is applied. For in vitro and in vivo experiments, droplets are 
generated as PFD (carrier fluid), diluent (200 nM IS, 0.2% acetic acid), and dialysate are flowed 
into a Valco 
Instruments Co., 
Inc.(Houston, TX) 50 
µm i.d. cross junction 
at 0.5, 0.25, and 0.25 
µL/min, respectively, 
using syringe pumps to 
control flow. The 
dialysate emerging 
from the MD probe is 
diluted 1:1 with 
incoming diluent and 
the resulting mixture is 
segmented into 3 – 8 
nL droplets at 1 – 3 Hz 
and exported into a 2 – 
5 ft length of 150 µm 
i.d. x 360 µm o.d. PFA 
tubing. The resulting 
Figure 3-1.(Top Left) MS/MS trace of the calibration curve for ACh with 5 droplets for each of the 6 
calibration levels. (All other graphs) Average signal intensity vs. concentration to generate a 6 point 
calibration curve with error bars for each of the target neurochemicals. These are the curves used for 
quantitation during one day of in vivo experiments (09/21/20). LOD is calculated using the limit of 




droplets were measured under a microscope to calculate average size of droplets in a train before 
taking to MS for analysis. An illustration of droplet generation can be seen in Appendix 1. 
Calibration Curves. Calibration curves were obtained daily prior to collecting in vivo 
samples. Stocks were thawed, diluted 10-fold, and serial diluted (1:2:2:2.5:2)  in 33% PO4 aCSF. 
For potassium stimulation experiments where abnormally high neurotransmitter concentrations 
were expected, one additional concentration level was added at five times the standard high point. 
Five droplets are generated for each concentration level, and the middle three are averaged for a 
triplicate calibration curve with standard deviation (SD).  
nESI-MS/MS. Zero-dead-volume Picoclear unions (New Objective, Woburn, MA) were 
used to transfer droplets to nESI emitters. Emitters were pulled from 50 µm i.d. x 360 µm o.d. 
fused silica capillary to an i.d. of 15 µm and coated with conductive platinum (FS360-50-15-CE, 
New Objective, Woburn, MA). Direct droplet infusion was carried out at 50 nL/min using 1.4 kV 
capillary voltage. All important final nESI and MS/MS parameters can be found in Table 3-2. 
Mass spectrometry analysis was performed on a Micromass Quattro Ultima triple-quadrupole mass 
spectrometry (Waters, 
Milford, MA). All 
experiments were 
performed in MS/MS 
mode in single reaction 
monitoring (SRM) mode 
to scan for multiple mass 
transitions at the same 
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time. Signal from a droplet is defined as the average of the points across a droplet. 
Microdialysis Probes. Custom concentric 2 mm microdialysis probes were constructed 
for in vitro temporal resolution and in vivo sampling experiments. Inlet and outlet fused silica 
capillaries (40 µm i.d. x 110 µm o.d.) were glued together offset by 2 mm and inserted into a 4 
mm piece of regenerated cellulose dialysis membrane (18 kDa MWCO, Spectrum Life Sciences 
LLC., Rancho Dominquez, CA). The distal membrane tip was sealed with an epoxy (Loctite, West 
Lake, OH) 100 μm from the inlet capillary. Dead volume within the membrane was eliminated by 
sealing the proximal end of the membrane around the inlet/outlet capillaries with epoxy and 
allowing it to wick into the membrane until it was within 100 – 200 μm of the probe active area. 
The probe was then secured within a 10 mm (25 G) piece of stainless steel hypodermic sheath 
tubing (Small Parts Inc., Logansport, In). A fused silica injection shank (75 µm i.d. x 150 µm o.d.) 
was added adjacent to the center of the membrane for 100 mM K+/100 μM d-amphetamine 
injections. A custom designed 3D printed probe holder (VisiJet M3 Crystal, 3D Systems, Rock 
Hill, SC) was used to secure the probe. A 150 µm i.d. x 360 µm o.d. fused silica sheath was added 
to the outlet capillary to enable direct connection to a 50 µm i.d. cross junction for droplet 
generation.  
In vivo Microdialysis Sampling. For in vitro recovery and temporal resolution 
experiments, microdialysis probes were inserted into a stirred vial of 2 mL of aCSF maintained at 
37 ˚C. To estimate system temporal resolution, a rapid physiological concentration change was 
simulated by spiking 10 μL of a 10 μM (per 50 µM change desired) standard mix into the stirred 
vial. In vivo neurochemical measurements were performed in anesthetized male 25 – 30 g C57BL/6 
mice (Envigo, Haslett, MI). Briefly, mice were anesthetized using 2 – 3 % isoflurane and mounted 




was then implanted into the striatum using the following coordinate with respect to bregma: 0.6 
mm anterior, ±1.75 mm lateral, and 4.2 mm ventral to the surface of the brain. Once lowered into 
place, probes were flushed continuously with aCSF for 15 min prior to droplet collection. As 
previously described, droplets were generated directly from the outlet of the MD probe. For 
neurotransmitter stimulation experiments,  either 100 mM K+ aCSF or 100 μM AMPH solution 
were administered locally through the probe injection shank at 1 µL/min for 30 s, totaling 500 nL. 
For high potassium stimulation, high potassium aCSF was administered at 0 min and 5 min for a 
sampling period of 0 – 10 min. For AMPH stimulation, AMPH solution was administered at -1 
min for a sampling period of 0 – 5 min.  
LC-MS/MS. Chromatographic separations were conducted on an Agilent 1290 HPLC 
interfaced to an Agilent 6410 triple quadrupole mass spectrometer using a Phenomenex Kinetex 
C18 chromatography column (100 x 2.1 mm, 1.7 µm, 100 Å). Mobile phase A and B consisted of 
water containing 10 mM ammonium formate/0.15% formic acid (v/v) and acetonitrile, 
respectively. The gradient used was as follows: initial, 5% B; 0.01 min, 19% B; 0.68 min, 26% B, 
1.05 min, 75% B; 1.8 min, 100% B; 2.8 min, 100% B; 4 min, 5% B; 5.0 min, 5% B at 600 μL/min. 
The autosampler was kept at ambient temperature, and the column was held at 30 °C, with 5 µL 
sample injection volumes. MD fraction were collected during in vivo experiments to be analyzed 
LC-MS analysis. For fraction collection, PFD flow was stopped, and the diluent and dialysate flow 
rates remained at 0.25 µL/min each into the microfluidic cross. One fraction was collected every 
5 min at 0, 5, 10, and 15 min (2.5 µL each), stored at -80 ⁰C, and thawed for analysis. Upon 
thawing, the fractions were subject to benzoyl chloride derivatization prior to analysis.46 For 
benzoylation, two parts sample are mixed with one part 100 mM sodium carbonate, one part 2% 




MeOH/water (v/v) added, step wise. The mixture was vortexed for 10 s after each addition. The 
internal standard mixture is comprised of analyte standards derivatized by the same procedure 
using C13 benzoyl chloride as the derivatizing agent. 
Results and Discussion 
 
MS/MS and nESI Conditions. The method developed in this study aims to significantly 
improve the temporal resolution typically obtained in microdialysis-based neurochemical 
monitoring while maintaining the advantage of monitoring many neurochemicals simultaneously; 
however, many neurochemicals, such as many monoamine acid neurotransmitters (i.e. DA, NE, 
Epi, 5HT, ACH), have low nanomolar basal levels in various brain regions, rendering many modes 
of analysis difficult or impossible due to insufficient LODs. To achieve sufficient LODs by MS 
for seven different neurochemicals including trace neurotransmitters DA, 5HT, and ACh, low-
flow nESI is combined with the sensitive and selective MS/MS mode of SRM. Many variables are 
tuned for nESI and MS/MS to improve detection sensitivity, signal reproducibility, and the signal-
to-noise ratio (S/N) for LOD optimization (Table 3-2). Though the optimization of many different 
parameters contributed to LOD improvements, three key conditions had a relatively large impact 
on LODs including flow regime (nESI vs ESI), sample matrix composition, and MS/MS scan 
speeds (dwell, Figure 3-2). Though each offered improvements for most/all target analytes, 
adjusting each condition offered varying degrees of improvement for each analyte. True nESI is 
achieved at low nL/min flow rates (0 – 50 nL/min) and has been shown to offer drastic 
improvements to ionization efficiency and reduction of ionization suppression.29,34,36 Here, we 
compared a nESI flow regime (50 nL/min with 15 µm i.d. emitter) to a flow regime closer to 
standard ESI (500 nL/min with 30 µm i.d. emitter, Figure 3-2A). The low-flow method offers 3-




the ionization suppression from aCSF, a 
degree of suppression remains. 
Phosphates, a component of standard 
aCSF, are known to cause ionization 
suppression in ESI.145 To further alleviate 
the suppression, aCSF with 33% of the 
standard phosphate (PO4) concentration is 
used for standards and low concentration 
acetic acid is added to the matrix, offering 
a 4-fold increase in signal intensity and 
nearly ½ the noise for DA, as well as 
reduced SD in the blank (Figure 3-2B). 
Finally, decreased interscan delays and 
longer dwell times can allow for 
improved signal as a result of longer 
signal collection periods. Applying a 100 
ms dwell time increased from 30 ms 
allowed for signal and noise to be 
distinguished for 150 nM Glu, offering 
nearly a 3-fold-improvement in signal 
intensity (Figure 3-2C).  
In Vitro. Droplet generation and 
temporal resolution of the system were 
Figure 3-2. (A) Low infusion flow rates (50 nL/min) and smaller nESI emitter 
i.d. (15 µm) allow for smaller droplets (4.4 nL) and improved analyte response 
and S/N over a higher infusion flow rates (500 nL/min) and larger i.d. nESI 
emitter (30 µm), which required 40 nL droplets. ACh is shown for this 
comparison. (B) An adjusted matrix with 33% of the standard PO4 
concentration in aCSF along with a final concentration of 1% concentration 
acetic acid compared to standard aCSF with no acid. DA is shown for this 
comparison (C) Increased dwell time (100 ms) for the MS/MS scans vs a 




explored and improved during in vitro experiments via MD sampling from a stirred vial. 
Parameters including flow rates, probe dimensions, and droplet generation devices were evaluated. 
In theory, the various flow rates used in this system (carrier phase, diluent, and perfusate) can be 
manipulated to control droplet generation frequency, droplet size, and the degree of analyte 
diffusion before segmentation. However, flow rates for PFD, diluent, and perfusate of 0.5, 0.25, 
and 0.25 µL/min, respectively, are maintained in order to (A) maximize analyte recovery across 
the dialysis membrane and (B) limit the total dialysate volume that requires MS analysis, since the 
nESI-MS/MS method requires 20-fold lower flow rates for analysis and reasonable throughput is 
needed. 
While low microdialysis flow rates correspond to high analyte recovery, low flow after the 
dialysis membrane can negatively impact temporal resolution. At lower flow rates, axial dispersion 
within the sampling flow path contributes to significant broadening of analyte concentration zones 
prior to collection,146 ultimately precluding capture of rapid concentration changes. To preserve 
dynamic sample information, pre-droplet generation volume was limited by designing a 
microdialysis probe using low i.d. capillary, filling all non-active area membrane volume with 
epoxy, and directly mounting the droplet generation cross to the probe outlet. Additionally, three 
microfluidic crosses were evaluated for droplet formation (50 µm, 100 µm, 150 µm i.d.). 
Ultimately, the 50 µm i.d. cross was selected for its low dead volume and smaller droplets. 
The temporal resolution of the system was measured during in vitro experiments. A stirred 
vial was sampled using an MD probe while the concentration was adjusted, and the resulting 
droplets were analyzed by the developed MS method (Figure 3-3A). temporal resolution was 
measured three times across two different concentration transitions (0 to 50 nM, 100 to 400 nM) 




transition does not impact temporal 
resolution. The temporal resolution is 
calculated for each replicate based on 
the number of droplets during the 
transition multiplied by the time taken 
to generate each droplet (determined 
by average droplet volume in a train 
divided by aqueous flow rate during 
generation). The transition is defined 
as all droplets lying between 10% 
above the average low concentration 
signal intensity (i.e. 0 nM ACh) and 
10% below the average high 
concentration signal intensity (i.e. 50 
nM ACh, Figure 3-3B). The triplicate 
temporal resolution measurement 
across the two concentration transitions yielded excellent reproducibility (3.6% RSD) with a 
temporal resolution of 10.75 ± 0.39. Though a previous method was able to achieve ~5 s temporal 
resolution for ACh,24 a slightly lower temporal resolution is expected in this system from increased 
diffusion caused by a lower perfusion flow rate (0.25 µL/min vs 1.0 µL/min).  
In vivo. The developed system was applied to neurochemical monitoring during high 
potassium and AMPH stimulations. For high potassium administration, the striatum was sampled 
over 10 min, during which 500 nL of 100 mM KCl (1 µL/min for 30 s) was administered at two 
Figure 3-3. To measure the temporal resolution of the system from sampling to mass 
analysis, stirred vial experiments were performed in triplicate for test compound 
ACh. temporal resolution measurements were performed by spiking sample into a 
stirred vial, sampling by MD, segmenting into droplets, and analyzing by MS. The 
average temporal resolution and error of the three transitions are reported. (A) A raw 
MS/MS trace of in vitro droplet analysis for ACh. (B) The middle of each droplet is 
average and correlated to real time based on the droplet volume/generation frequency 




different time points, starting at 0 min and 5 min during sample collection, respectively, with a 
dead time of 2.5 min. Three biological replicates were obtained over two mice (two hemispheres 
in one mouse). Droplet volume for the three replicates ranged from 5 – 5.7 nL, depending on the 
replicate. The average of all three replicates (% baseline) is plotted with the standard error of the 
mean (blue-dotted line) for all compounds (Figure 3-4, Figure 3-5A).  
To compare the difference in 
temporal resolution and monitoring 
dynamics between the droplet-nESI-
MS/MS method and a conventional LC-
MS/MS method, five-minute fractions 
were collected from the same mice and 
analyzed by LC-MS/MS. In Figure 3-4, the 
averaged traces for 5HT, GABA, DA are 
plotted from both analysis methods. 
Though each method was used to analyze 
MD fractions collected over 10 min, the 
LC fraction method provides only three 
time points which offers a temporal 
resolution of 5 min, while the droplet 
fraction method provides over 900 points 
with a temporal resolution of 10.75 s. This difference is clearly reflected in the neurotransmitter 
dynamics that can be seen in each trace. Though the LC fraction method shows similar percent 
baseline changes in the neurotransmitter concentrations as the droplet fraction method, important 
Figure 3-4.  In vivo experiments using MD probes sampling the striatum 
over a 10 min collection period. 500 nL of high potassium aCSF was 
administer over 30 s beginning at 0 and 5 min, with an approximate 2.5 min 
dead time. Three biological replicates were obtained over two mice (one 
mouse with two hemispheres). Points converted to percent baseline to 
normalize for concentration differences and all three traces were averaged. 
SEM shown as a blue-dotted line. Gray squares and connecting lines 




temporal information is missing such as duration between stimulation and response, duration of 
elevated neurotransmitter concentrations, and speed of neurotransmitter increase/decrease. On the 
other hand, each of these details can be seen in the droplet fraction method, showing much more 
suitability for monitoring short-term dynamics and rapid neurotransmitter changes. Similar 
neurochemical changes in response to high potassium levels have been reported for DA, ACh, Glu, 
GABA, and 5HT.98,139,147–149 Accuracy and quantitative capabilities of the droplet-MS method are 
also assessed by comparison of the basal concentrations determined by each method (Figure 3-
5B). Though the representative averages obtained by each method show notable error (ranging 
from 38 – 137%), there was a high degree of variation in the basal concentration measured between 
Figure 3-5.  (A) In vivo experiments using MD probes sampling the striatum over a 10 min collection period. 500 nL of high potassium aCSF was 
administer over 30 s beginning at 0 and 5 min, with an approximate 2.5 min dead time. Three biological replicates were obtained over two mice (one 
mouse with two hemispheres). Points converted to percent baseline to normalize for concentration differences and all three traces were averaged. SEM 
shown as a blue-dotted line. Gray squares and connecting lines represent LC fraction method, with fractions collected over 5 min intervals. (B) Basal 








each animal/in vivo experiment that may be a result of biological differences or MD probe 
differences. Based on a paired t-test of the basal concentrations determined for all target 
compounds by each method and the standard deviation between each biological replicate, the two 
methods measured statistically similar basal concentrations (P = 0.26). The basal levels measured 
for each neurochemical by droplet-MS were above the LOD for the method, allowing for reliable 
quantification of baseline concentrations. Additionally, the method generally showed low droplet-
to-droplet concentration variation at the basal level, with relative standard deviation among 
droplets at basal levels averaging 36, 50, 32, 23, 54, 28, and 30% for Ado, 5HT, DA, Glu, Gln, 
ACh, and GABA, respectively. These variations are slightly higher than those from in vitro 
experiments (10-20% droplet-to-droplet variation for DA, ACh), likely due to the presence of a 
complex matrix rather than water and lower basal concentrations for in vivo experiments than what 
was used for in vitro. 
Similarly, the striatum was sampled 
over a 5 minute period as 500 nL of 100 µM 
AMPH was administered locally (1 µL/min 
for 30 s). Four biological replicates were 
obtained over three mice (two hemispheres 
in one mouse). As expected, AMPH elicits 
a much more selective response, where 
quantifiable changes are only present in DA 
and 5HT (Figure 3-6), and the remaining 
compounds stayed at basal levels during 
AMPH stimulation.  In addition to the seven 
Figure 3-6. In vivo experiments using MD probes sampling the 
striatum over 5 min with 500 nL of  100 µM AMPH administered 
over 30 s starting at -1 min. Four biological replicates were obtained 
over three mice (one mouse with two hemispheres). Points converted 
to percent baseline to normalize for concentration differences and all 
three traces were averaged. Black dots and connecting lines represent 
droplet fraction method with SEM shown as a blue-dotted line. 
AMPH was monitored for one of the four replicates. 




neurochemicals, AMPH in the extracellular space was also monitored for one of the four replicates, 
allowing for further correlation between drug levels and neurotransmitter response (Figure 3-6C). 
Though DA was expected to increase in the presence of AMPH, we observed a delayed response, 
where DA concentrations began to increase approximately 30 s after AMPH appeared (Figure 3-
6A). DA increased to 400% of baseline levels within 30 s, and experienced an extended duration 
of increased baseline, decreasing to 300% baseline after three minutes of increased response. The 
extended increase in DA levels is most likely caused by the lingering presence of AMPH (Figure 
3-6C). AMPH is also known to increase extracellular 5HT.150–152 Here, we observed 5HT 
experiences a brief but sharp increase from baseline approximately 60 s after AMPH appeared, 
also correlating to the time of maximum DA concentration (Figure 3-6B). Though the observed 
5HT response has relatively high variability across the biological replicates, it is believed to be a 
biological response as its response to AMPH is temporally similar to DA and the IS (d45HT) 
during exhibited no change in signal intensity for the in vivo experiment with the largest 5HT 
baseline change (Figure 3-7). The traces shown are representative averages and SEMs of all biological 




Utilizing the sensitivity and 
selectivity of low flow nESI paired 
with MS/MS in a triple quadrupole 
mass spectrometer, we have developed 
a method to monitor several low 
abundance neurochemicals from dialysate simultaneously with LODs as low as 2 nM (ACh). 
Figure 3-7. Validation of the biological response of 5HT to AMPH presence 
in one of the AMPH stimulation replicates. The black dots and connecting 
lines represent 5HT concentrations collected during AMPH stimulation and 
the gray dots and lines represent the internal standard d45HT used during 




Pairing this analysis with droplet microfluidics yields 10.75 s temporal resolution and can generate 
down to 3 nL dialysate fractions at up to 3 Hz from an MD probe. In principle, even better LODs 
and temporal resolution could be obtained if a newer MS were utilized, as it may offer improved 
ion transmission and faster scan speeds. The monitoring dynamics of the developed system is 
compared to a conventional LC-MS/MS assay for MD neurochemical monitoring, where the 
droplet fraction method offers far more temporal information. The system is also applied to 
monitoring short-term neurotransmitter dynamics in response to selective drug stimulation 
(AMPH). This method demonstrates excellent suitability for short-term neurotransmitter dynamics 
and can offer important insights that may not be attained by LC-MS for MD analysis without 
sacrificing the chemical range offered by MD sampling. Finally, the inclusion of many 
neurotransmitters in a method with high temporal resolution offers a distinct benefit of potential 
to correlate the various neurotransmitter changes with one another, a feature that is unavailable in 



















High Throughput Liquid-Liquid Extractions with Nanoliter Volumes Using Slug Flow 
Nanoextraction 




Extractions are widely utilized in chemistry and serve a variety of purposes including 
compound isolation, partitioning measurements, analyte preconcentration, and sample preparation. 
The most commonly used extraction techniques are solid phase extraction (SPE) and liquid-liquid 
extraction (LLE). Though  SPEs have several advantages, LLE remain popular because they are 
cost effective, easy to achieve, and require little method development.44,153–155 Much effort has 
been allotted to reducing the size and scale of LLE. Liquid phase microextractions (LPME)44,156 
are more rapid, use lower volumes, and better facilitate pairing with analytical techniques 
compared to their macroscale counterparts.157,158  
 Liquid phase extractions that can be performed in-line or on-line with analytical techniques 
or detection methods are attractive for increased automation and throughput. This goal has led to 
the development of hollow fiber based microextractions,159–161 single drop microextractions,162,163 
liquid-liquid-liquid microextractions,164,165 and electromembrane extractions.166,167  Besides 
facilitating coupling to analytical techniques,158 these methods also allow for reduction of sample 
and extraction solvent volumes to the hundreds of microliter range rather than the milliliters typical 




by using microfluidics. Several microfluidic LLE devices have been developed to allow for 
quicker and lower volume extractions including parallel flow devices,168,169 on-chip dispersive 
liquid-liquid extractions,170 Y-junction or T-junction devices for extraction,86,171 and others. 
Microfluidic LLE techniques use microliters or less of sample and solvent and have sub-minute 
equilibration times, though these are still limited to a single sample extraction at a time.  
 A recently reported variant of low-volume LLE is slug flow microextraction (SFME).172 
In this method, 5 µL of sample and 5 µL of organic extraction phase are placed adjacent to one 
another in a fused-silica capillary nanoelectrospray ionization (nESI) spray tip. Tilting the capillary 
back and forth resulted in the slugs flowing back and forth in the capillary and interacting at their 
interface to yield a rapid extraction. The analyte-enriched extraction phase could then be pushed 
to the end of the tip and quantitatively analyzed by nESI-MS. SFME is a simple, rapid, and low-
volume sample preparation method to reduce matrix effects for nESI-MS analysis of samples, and 
was found to drastically reduce the limits of detection for several analytes. SFME has been utilized 
in a variety of ways including determination of trace amphetamine-type drugs when coupled to 
paper spray-MS,173 three-phase SFME for polar analyte determination,165 and for preconcentration 
of analyte from bulk sample.174  
Here, we report slug-flow nanoextraction (SFNE), a method that combines principles of 
SFME and droplet microfluidics. In SFNE, sample and extraction solvent plug pairs (“phase 
pairs”) are juxtaposed in a tube, similar to SFME; however, a multitude of individual pairs are 
separated by an immiscible oil, like that used in droplet microfluidics,79 so that linear arrays of 
samples, up to 60 in this case, can be entrained in a single capillary or channel. The method uses 
down to 5 nL of sample, 3 orders of magnitude lower volume than reported by previous SFME 




the tube so that the SFNE format is high-throughput, with 60 extractions completed in under 5 
min. Because the method uses continuous flow in one direction, it can be coupled to different 
detectors to facilitate diverse applications. The method is coupled with on-line UV detection for 
measurement of octanol-water coefficients (Kow, log D, log P) of drugs and coupled to ESI-MS/MS 
with improved LODs  for determination of drugs in biofluid samples. 
The Kow is an important value to know for environmentally and pharmaceutically relevant 
compounds.175 The shake-flask and slow stirring methods are traditional means for determining 
Kow; however, they have several drawbacks including requiring large volumes (milliliter range) 
and long times (minutes - hour).176–178 Chromatography can be used for approximating Kow. This 
approach can have advantages in reproducibility, insensitivity to impurities, and sometimes speed; 
but it is limited in the molecules that are amenable.175,179 SFNE allows for direct determination of 
Kow using nanoliters of volume per extraction and rapid extraction times. Since this method uses 
an octanol-water extraction similar to the shake flask method, it is applicable to a broad range of 
compounds and makes a direct measurement of Kow rather than approximation as with 
chromatographic methods. 
For ESI in MS, ionization suppression of analytes in complex mixtures can reduce signal 
making determinations challenging,25 a common problem in biological sample analysis. Because 
of this, MS analysis often requires sample preparation, such as extraction, prior to analysis.44 
Selectively isolating a compound / compounds with an extraction prevents or lessens ionization 
suppression by removing compounds that compete for ionization. Employing SFNE paired with 
MS, the extraction step is performed in-line, reducing the sample, solvent, and time consumption 
normally associated with sample preparation. Additionally, the segmented flow format of the 




that SFNE-MS improves S/N for several drugs analyzed from human plasma, artificial cerebral 
spinal fluid, and synthetic urine. 
Materials and Methods 
  
 Reagents and Materials. All chemicals and solvents were purchased from Sigma-Aldrich 
(St. Louis, MI, USA) unless stated otherwise. PFD was purchased from Oakwood Chemical 
(Colombia Hwy, Estill, SC, USA). Drug standards were prepared in HPLC-grade water at 1 – 10 
mM, aliquoted, and stored at -20 ⁰C. Standards were thawed daily for use and diluted to the desired 
concentration. Rhodamine 6G (Rh6G) stock was prepared at 10 mg/mL and stored at room 
temperature. Aliquots were taken for daily use. For molecules that required a calibration in the 
extraction phase, acetaminophen (ACP) and Rh6G were prepared in 1-octanol (≥99%) and 
chloroform (≥99.5%), respectively and serial diluted. Surine™ negative urine control was 
purchased from Cerilliant (Paloma Dr., Round Rock, TX, USA). Pooled human plasma samples 
were obtained from Michigan Regional Comprehensive Metabolomics Resource Core. aCSF was 
prepared in 500 mL of water with 145 mM NaCl, 2.68 mM KCl, 1.4 mM CaCl2 • 2H2O, 1.01 mM 
MgSO4 • 7H2O, 1.55 mM Na2HPO4, and 0.45 mM NaH2PO4 • H2O at pH 7.4. Sheath liquid for 
ESI consisted of 50:50 MeOH:H2O (v:v) with 0.1% formic acid (FA).  
 Droplet Generation and Analysis. Hamilton (Reno, Nevada, USA) gastight syringes 
were used (25 µL, 1 mL) with Chemyx Inc. Fusion 400 syringe pumps for infusion. For droplet 
generation, a Harvard Apparatus PHD 2000 programmable syringe pump was used. Single-phase 
droplets were generated using a syringe pump drawing at a rate of 300 nL/min using a 25 µL 
syringe with a 15-30 cm length of 100 µm inner diameter (i.d.) 360 µm outer diameter (o.d.) PFA 




unions from Valco Instruments Co., Inc. (Houston, TX, USA). Droplet generation was performed 
using an XYZ-position manipulator to draw from a 384-microwell plate as described before.99,180 
The positioner was used to alternate the tubing between the fluorous carrier fluid  PFD (0.5 s draw 
time) and aqueous sample (2 s draw time); 200 single-phase droplets were generated before 
analysis. The same draw rate and syringe were used for two-phase slugs with the addition of 
extraction phase and air for segmentation. During two-phase slug generation, an XYZ-positioner 
would move the tubing to sequentially draw PFD, air, extraction phase, and aqueous phase 
repeatedly as shown in Figure 1.99  
A syringe and line of tubing with droplets would be taken to either MS, UV, or laser-
induced fluorescence (LIF) for analysis. For LIF, a Coherent (Santa Clara, CA, USA) Sapphire 
488-20 CDRH laser was used with a Zeiss (Jena, Germany) D-104 microscope and a PTI 
(Piscataway, NJ, USA) 814 photomultiplier, with emission collected through a 530 nm bandpass 
filter. For UV detection, a Linear (Auburn, CA, USA) UVIS 200 variable wavelength absorbance 
detector with a slot for a capillary flow cell was used for detection of analytes in extraction on-line 
with the wavelength set to 243 nm. For optical detection modes, the tubing was aligned with the 
light source and flowed at 500 nL/min. For MS, the tubing was placed through the sheath-flow 
sprayer so that the tip emerged. The contents then flowed at 500 nL/min and the sheath-flow at 10 
Table 4-1. The drugs used for MS experiments were investigated for optimal transitions, fragmentor voltages and collision energies 
individually. Other MS settings were investigated for signal improvements including drying gas temperature (175 C), drying gas flow (10 
L/min), nebulizer gas pressure (7 psi), and capillary voltage (3 kV). The resulting values were used for MS/MS via single reaction monitoring 
mode (SRM), where every transition is monitored throughout the infusion 




µL/min. Droplets or two-phase slugs were analyzed using single reaction monitoring (SRM) mode 
for MS/MS in all MS experiments, using previously determined and optimized transitions for each 
analyte of interest (Table 4-1). As previously reported, the PFD does not support ESI because it is 
inert and non-conductive.1,99 We typically observe that PFD forms a bead on the top of the ESI 
source and flows away. Little contamination of the mass spectrometer has been observed. ESI was 
carried out using an Agilent CE ESI-MS Sprayer and a syringe pump for sheath-flow with an 
Agilent 6410B Triple Quadrupole controlled by Agilent Masshunter software. 
Results and Discussion 
 
SFNE relies on segmented flow wherein extraction solvent plugs (organic phase), analyte 
plugs (aqueous phase), and carrier fluid plugs (an immiscible fluid) are arranged in order and 
pumped through a conduit such as a capillary tube (Figure 4-1). For this work, sample and 
extraction phase plugs were assembled using a syringe pump to pull fluids into a tube and XYZ-
positioner to move the tube inlet from well-to-well on a 384 microwell-plate (Figure 4-1A). The 
multiphase fluid, consisting of arrays of sample-extraction phase pairs, is pumped toward an online 
detector for analysis (Figure 4-1B). In this work we used PFD as the carrier fluid because it is 
immiscible with both water and all tested extraction solvents. Organic phase plugs tend to flow 
faster through the PFD than aqueous plugs such that an organic phase plug would catch the 
upstream aqueous phase plug to initiate an extraction (Figure 4-1C). To prevent different sample 
pairs from interacting with each other, an air bubble was positioned between the phase pairs 
(Figure 4-1A and 4-1B).  Extractions that occur with this method rely on internal mixing resulting 
from circulation of the contents within a droplet caused by friction from viscous drag as droplets 
flow throughout the tubing (Figure 4-1D).79,181 This mixing constantly refreshes the interface 




Using rhodamine 6G (Rh6G) to observe partitioning, we observed extractions within seconds (< 
5 s) once the interface of the two-phase slug is formed. The rapid extraction can be attributed to 
both rapid mixing and miniaturization. SFME, which presumably achieves a similar internal 
recirculation of plugs to establish partitioning equilibrium, required 5 manually induced extraction 
cycles for 5 µL samples.172 Upon scaling the volumes down 3 orders of magnitude for SFNE, the 
extraction time/flow distance required for partitioning to reach equilibrium is dramatically 
decreased. This near-immediate extraction and the in-capillary array of extractions makes this 
technique compatible for hyphenation with other techniques and for many extractions to take place 
simultaneously. The sample volume and time required for extraction are considerably lower than 
Figure 4-1. (A) The two-phase slug generation process is shown, where a length of PFA tubing with applied vacuum is sequentially dipped in 
PFD, extraction solvent, and aqueous sample. For most experiments, an air plug is also included before each extraction phase. (B) Once a line 
of tubing is filled with phase pairs, flow is driven towards the outlet allowing the extraction phase to accelerate and contact the sample. The 
tube can be paired with a variety of detectors, where extractions occur while in-transit to an online detector. (C) Shown are three time points 
for a single phase pair as the two phases are interfaced. Though initially far apart, the organic plug accelerates towards the leading aqueous 
plug, forming a partitioning interface and allowing extraction. The photographs show the appearance of the phase pair before and after the 
extraction occurs, where the second image shows that a majority of Rh6G has transferred from aqueous to organic. (D) Due to the internal 
mixing within the low volume droplets, contents of the aqueous sample partition rapidly into the extraction phase mode (SRM), where every 




other reported LPME techniques such as hollow fiber liquid-phase microextractions,182,183 
dispersive liquid-liquid microextractions,184,185 and SFME. These techniques require between 
several microliters to milliliters of each phase and take several minutes for extraction. 
We sought to compare the results obtained by SFNE to traditional LLE using a flask. To 
do so, we compared partitioning of 100 µM Rh6G between water and chloroform by the two 
methods. For SFNE, 60 phase pairs were formed. The resulting plugs were flowed through an LIF 
detector for on-line detection of the resulting distribution of Rh6G (Figure 4-2A). As shown by 
the trace, each droplet pair is detected as a fluorescent peak, and each pair has a distinct step from 
lower to higher signal resulting from detection in each phase. The signal step is not as sharp as 
might be expected from the images shown in Figure 4-2A. This phenomenon is possibly due to 
the laser spot not being focused to a sufficiently small spot to detect the change at the interface. It 
may also reflect aberrations due to a curved interface between the phases. For analysis, we used 
10 randomly selected phase-pairs throughout the trace for detection of signal in each phase. For 
comparison, we also performed extractions of the same concentration of Rh6G using the same 
sample and extraction phase by a microshake-flask extraction. In this method, 200 µL of each 
phase were vortexed in a 600 µL vial for 1 min and centrifuged to eliminate any emulsions. Three 
plugs from each of these phases were generated into a length of tubing and measured by LIF 
(Figure 4-2B). For each of these modes of extraction, the ratio of the signal in extraction phase 
over signal in aqueous phase was taken to show the relative partition coefficients obtained by each 
method of extraction (Figure 4-2C). The results show that partition coefficients between the two 
methods are the same (based on P-value determined by a t-test). These results confirm the visual 




During creation of phase pairs, it is possible to vary volume ratios of the 2 phases to affect 
the extraction. Such variations can be useful, for example to concentrate analytes into one phase. 
The ability to control extractions in this way was tested by generating phase pairs in a train with 
different volume ratios, using 10 µM Rh6G as the analyte in water and chloroform as the extraction 
phase. The fluorescence signal in each portion of each extraction slug was measured by LIF. Figure 
4-3A shows the measurements of fluorescent signal in the phase pairs as the volume ratio (aq/org) 
increases. With increasing ratio of aqueous volume to extraction phase volume, the signal increases 
in the organic phase and the aqueous portions of the phase pairs elongate and the organic portions 
Figure 4-2. (A) A train of phase pairs with extraction solvent CHCl3 was generated and the partitioning of fluorescent dye Rh6G was measured 
by LIF. Though initially dissolved in water, most of the rhodamine partitioned into CHCl3 by SFNE. The variation in signal intensity is due to 
the variations in volumes between phase pairs. (B) Similarly, an offline extraction via microshake-flask extraction was performed with the 
aqueous rhodamine and extraction solvent CHCl3. Three plugs of each layer were generated and analyzed by LIF. (C) The ratios of signal from 
LLE and SFNE were graphed and show similar extraction efficiency. The increased ratio by SFNE is due to a slightly higher volume of 




narrow. These data follow expected trends. As the percent organic volume per phase pair 
decreases, the concentration in organic phase is expected to increase as shown the following 
equation, 




where Caq,eq and Caq,initial are the equilibrium and initial concentrations in aqueous, Corg,eq is 
the equilibrium concentration in organic, K is the partition coefficient, and Vo and Vaq are the 
organic and aqueous volumes.156 This equation reasonably matches a plot of volume ratio (Vo/Vaq) 
against concentration (determined by external calibration) in the organic phase (where K = 4.8) as 
shown in Figure 4-3B. Manipulation of the phase ratio can be useful in different ways. For 
example, extracting from a large volume sample into a relatively small extraction phase can help 
concentrate analytes. In Figure 4-3B, Corg is over 5 times higher when the phase pair volume ratio 
is changed from 1.6 to 0.08. This technique can be implemented for preconcentration in SFNE as 
previously demonstrated in SFME.174 
As illustrated by the results from Figure 4-2, the method allows arrays of samples to be 
extracted at one time. In this experiment, a throughput of 3.6 s per extraction was achieved during 
detection by LIF with a total of 32 extractions. However, SFNE is not limited to this throughput 
or extraction array quantity. The number of extractions that can be achieved in a single run is 
dependent on the length of capillary tubing used. 
Determining Kow. A common use of LLE is to determine Kow. The Kow is used in the 
pharmaceutical industry to provide information on pharmacokinetics, bioavailability, and 
permeability through biological membranes.186 It is also important in environmental analysis as a 

















































determine if SFNE could be used for 
determining Kow with ACP as the test 
analyte. For this work, the droplets 
were passed through an on-line UV 
absorbance detector to measure the 
concentration in each phase. Figure 4-
4 illustrates a typical data trace from 
this experiment. The absorbance 
response trace includes a series of 
octanol droplets containing ACP from 
2.0 – 0.2 mM, followed by a series of 
water droplets containing ACP from 
1.0 – 0.1 mM. These sections of the 
trace allow calibration within each of 
the solvents used for the extraction. 
The next section of droplets contained 
5 plugs of each phase collected from a 
shake-flask extraction so that a 
comparison to the SFNE could be 
made. Finally, 12 SFNE two-phase 
slugs were passed through the 
detector. Having both calibrations allows for the concentration of ACP to be determined in each 
layer after extraction, giving an accurate Kow value. Each calibration curve in the experiment had 
Figure 4-3. Volume ratios of the two-phases where manipulated for each phase 
pair in a train. (A) Four pairs of high organic volume, similar volume of each, 
and high aqueous sample volume were generated and measured by LIF. (B) A 
plot of concentration in extraction phase at equilibrium vs. volume ratio for 
each phase pair. As the volume is manipulated to increase sample volume and 
lower extraction phase volume, the final concentration in the extraction phase 
increases, achieving a preconcentration effect. A trendline (dotted curve) was 
fitted to theoretical Corg,eq values obtained from Equation 4-1 (using K = 4.82), 
which fits the experimentally determined values. Performed with 10 µM Rh6G, 
with flow rates of 0.5 µL/min. 




good linearity (R2 ≥ 0.998). Using calibrations to determine concentration in each layer after 
extraction in each method, Kow (Coct/Caq) was calculated. The shake-flask yielded Kow of 2.48 ± 
0.02 (logK = 0.39) and the SFNE method determined a Kow of 2.49 ± 0.01 (logK = 0.40), showing 
no statistical differences. Previously reported logKow literature values for ACP range from 0.29 - 
0.51, further confirming SFNE provides an accurate measurement.188–191 SFNE can determine Kow 
with excellent repeatability, showing an RSD of 0.7%. 





















































Figure 4-4. (A) In a single experiment, acetaminophen Kow was determined by the common shake-flask method and SFNE using UV VIS 
detection. First, acetaminophen was calibrated from 1.0 – 0.1 mM in water and 2.0 – 0.2 mM in octanol. Second, plugs generated from 
each layer of the shake flask extraction were measured by UV. The shake flask extraction was performed by placing 100 µL of pure octanol 
and 100 µL of 1 mM acetaminophen (aq) into a PCR tube, vortexing for 1 min, and centrifuging for 5 min. Finally, two-phase slugs initially 
containing pure octanol and 1 mM acetaminophen (aq) were measured by UV. The Kow was determined from each method by determining 
concentration of acetaminophen in each layer using the calibrations and taking the quotient of Corg/Caq. (B) The calibration of ACP in each 
phase was plotted and showed good linearity. Error bars are present but hidden by markers. (C) Zooming in on a central phase-pair better 




In this experiment, extractions from the shake-flask method were added to the work-flow 
to obtain a comparison between SFNE and traditional means of measuring Kow; but, this addition 
is not required for determining Kow. Technology for determining partition coefficients has yet to 
achieve rapid and low volume techniques. With the SFNE method for Kow determination, two-
Figure 4-5. (A) In a comparison of SFNE-MS and single-phase droplet-MS, a train of phase pairs was generated with sample plug consisting 
of the drug mixture in plasma (1 µM) and extraction plug EtOAc. Each train consisted of 10 analyte containing phase pairs alternating with 
10 blank phase pairs. For single-phase droplet-MS, a droplet train consisting of the same sample layer was generated, without presence of 
an extraction phase, alternating 10 analyte containing droplets with 10 blank droplets. Each form of infusion was measured by ESI-MS/MS. 
The y-axis shows intensity normalized to the highest point between the two EIC traces. (B) Five drug compounds were analyzed by SFNE-
MS and single-phase droplet-MS from multiple biological matrices. Measurements made from each method used the same sample solutions 
on the same day, forming them into a train of two-phase/one-phase droplets for measurements. Average S/N calculated by subtracting 
average noise from each signal and dividing by the root mean square of the noise peaks. The average and standard deviation of these values 




phase slug generation and analysis by UV detection are automated. This format, along with near-
immediate extractions and potential for an array of compounds per experiment, allow for high-
throughput Kow measurements by SFNE. The low organic phase volume and amount of compound 
required for each measurement allow for greener chemistry, especially compared with other high-
throughput measurements which use high microliter to milliliter volumes of octanol per 
extraction.179,192 The benefits provided by SFNE are potentially significant given the widespread 
use of Kow.   
SFNE-MS. Most biological sample analysis by ESI-MS requires a sample separation or 
extraction step to reduce matrix effects such as ionization suppression.  Previous extractions used 
for ESI-MS are on microliter scale and are limited to a single sample per infusion.50,160,164,172 We 
tested the utility of SFNE paired directly with ESI-MS/MS for the determination of several drugs 
simultaneously in complex biological samples. Several extraction phases were investigated 
including CHCl3, dichloromethane (DCM), and ethyl acetate (EtOAc). EtOAc was the only 
extraction phase tested that showed significant signal response with MS and was selected for all 
SFNE-MS experiments in this work. Similarly, previously reported SFME-ESI studies found 
Table 4-2. Five drug compounds were analyzed by SFNE-MS and droplet-MS from multiple biological matrices. Measurements made from each 
method used the same sample solutions on the same day, forming them into a train of phase pairs/droplets for analysis. Also shown, LODs and 




EtOAc to be the most effective solvent for extraction and ionization.165,172–174 Fortunately, since 
EtOAc has a weak polarity, it is an effective solvent for extracting a broad range of compounds.  
To test the effectiveness of SFNE for reducing the effects of ionization suppression on 
analytes, SFNE-MS was compared to direct infusion of single-phase droplet samples under the 
same conditions for ionization and MS/MS analysis. Five drugs were tested including clemastine 
(Clem), dextromethorphan (DXM), doxylamine (Dox), diphenhydramine (DPH), and 
methoxyverapamil (MVER), all spiked to 
near therapeutic concentrations into 
human plasma. A summary of figures of 
merit from these experiments are given in 
Table 4-2. We found that SFNE prior to 
ionization resulted in higher signal 
intensity over direct infusion of single-
phase spiked plasma droplets (Figure 4-
5). In Figure 4-5A, in an infusion of DPH 
droplets in plasma, 20-fold higher 
maximum signal from an extracted ion 
count (EIC) was obtained by SFNE-
MS/MS over single-phase droplet-
MS/MS. Not only is signal intensity 
improved by SFNE, but also S/N. We see 
S/N from plasma for Clem, DXM, Dox, 
DPH, and MVER improve by 230, 1760, 

















































Figure 4-6. A comparison between droplet-MS and SFNE-MS on 
synthetic urine droplets containing 1 µM Dox (using EtOAc 
extraction phase for SFNE). Figure 4-6A shows the trace of droplet-
MS. There is a substantial amount of carry over that can be seen here, 
with 27% analyte carry over into the adjacent droplet prior to 
samples and 12% carry over into the adjacent droplet post samples. 
This carry over effect is greatly reduced in SFNE as seen in Figure 
4-6B, with 1.5% carry over before samples and 1.7% carry over after. 
The other tested compounds also show reductions in carry over using 




530, 900, and 400%, respectively (Figure 4-5B). The S/N improvements by SFNE shown in Figure 
4-5B are due to the extraction of the analytes by SFNE which reduces ionization suppression 
caused by components present in plasma such as salts, which will not extract into the ethyl acetate. 
Additionally, we observe that SFNE reduces the carry-over of analyte between phase-pairs 
compared to direct infusion by single-phase droplet-MS for many of the compounds. Though this 
effect is observed in plasma, it is even more apparent when using the SU sample matrix. An 
example of this effect is seen in Figure 4-6, where 1 µM Dox was spiked into SU and measured 
by single-phase droplet-MS and SFNE-MS. In single-phase droplet-MS, a carry-over of 27% and 
12% is observed in the droplet immediately before and after the samples, respectively; however, 
in SFNE-MS the carry-over is reduced to 1.5% and 1.7% before and after the phase pairs. The 
reduction in carry-over is most likely due to a combination of air plugs assisting segmentation and 
preferential partitioning into an extraction phase, helping to reduce uncontrolled cross-talk. 
In addition to analysis from plasma, SFNE-MS was tested on the drug mixture spiked into 
SU and aCSF (Figure 4-5B). All five drug compounds (MVER not included in aCSF) showed 
improved S/N by SFNE-MS over single-phase droplet-MS in all 3 matrices, with improvements 
ranging from 3 to 19-fold. Not only does SFNE-MS provide benefits over single-phase droplet-
MS, but it has many advantages over typical extractions before MS/MS analysis such as allowing 
for automated extractions and sample introduction since the partitioning occurs within the tubing. 
SFNE also allows for high-throughput analysis since an array of samples can be extracted in-line 
and directly infused every experiment, with sample introduction rates at approximately 6 s per 
phase pair (Figure 4-5), compared to the several minutes for a typical LPME per extraction 




extractions per infusion. Additionally, SFNE has nanoliter volume requirements which allows for 
negligible consumption of finite samples. 
To evaluate SFNE-MS/MS as a quantitative tool, calibration curves for the drug mixture 
in plasma were obtained (Figure 4-7A). Calibration curves for these 5 drugs were obtained over a 
range of biologically relevant therapeutic concentrations193 (10 – 0.1 µM) and showed acceptable 
linearity (R2 ≥ 0.98) (Figure 4-7B). Limits of 
detection in plasma were 7, 40, 60, 30, and 50 
nM for Dox, Clem, DXM, MVER, and DPH 
respectively, which were obtaining using 
approximately 2 volumes of aqueous sample 
per volume of extraction phase. Further 
adjusting the volume ratios, utilizing a newer 
mass spectrometer with enhanced ion 
transmission, and implementing nESI rather 
than ESI could possibly yield even better 
LODs. Table 4-2 shows calibration curve 
linearity and limits of detection for each 
individual compound, where reproducibility 
at the low concentration point ranged from 
1.8 – 15.3%. Compared to another relevant 
method (SFME), SFNE is able to detect 
significantly lower absolutely mass at 9 fg 
compared to the lowest reported LOD for 
Figure 4-7. Calibration curves from 0.1 – 10 µM were obtained for five 
drug compounds by SFNE-MS using SRMs to monitor each transition 
simultaneously. (A) Shown is the extracted SRM trace of the DXM 
transition that was used for calibration. A train of two-phase slugs was 
generated with five replicates of each concentration level to form the 
calibration. The outside slugs for each concentration were treated as a 
spacer or wash slug, and the inside three replicates had peak height 
averaged to obtain average signal response. (B) Dextromethorphan 
shows linearity across the calibration curve (R2 = 0.99). All compounds 
have an R2 value of at least 0.98 in their calibration curves. Omitting 
the high point in the curve yields an R2 value of 0.99 for all compounds. 
Reproducibility at the low concentration point for DXM was 5.9%. 
RSD for the low point of all compound calibration curves ranged from 




SFME of 150 fg. However, SFME was able to detect at a lower concentration (0.2 nM) than SFNE 
(7 nM). A number of differences in experimental conditions by contribute to the better LOD by 
SFME including use of: nESI, 10-fold dilution of blood (decreased matrix effects), and different 
instrumentation in SFME experiments.  
Conclusions 
 In this study, we have demonstrated SFNE as a novel LLE technique that allows 
for low nanoliter extraction volumes, extraction in seconds, and compatibility with on-line 
detectors. SFNE was demonstrated to be compatible with different extraction solvents (EtOAc, 
chloroform, octanol), three different detectors (UV, LIF, MS), and several different aqueous 
matrices with varying analyte concentrations. Due to these positive qualities, this technique can be 
used for a variety of applications. SFNE has shown utility for rapidly and accurately determining 
Kow using low volumes, consuming small amounts of analytes and allowing for greener chemistry 
due to lower organic solvent consumption. The small samples may also enable extraction for 
applications where nanoliter samples are generated such as single cells, laser capture 
microdissection, microdialysis samples from the brain, and droplet microfluidics reaction 
screening. SFNE has also shown utility for sample clean-up for ESI-MS, offering significant 
improvements in signal. However, SFNE has some limitations, including MS experiments being 
limited to EtOAc as the extraction solvent and the number of two-phase slugs that can be generated 
per experiment; though, lengthening the capillary and generating more two-phase slugs could 
allow for more extractions to occur in a single experiment. Future work for this will focus on 
development of an online slug flow generator. This device will allow for further applications 
including pairing with online sampling or other microfluidic devices. SFNE may also be 

































Liquid-liquid extractions (LLEs) are a fundamental tool useful for sample clean-up in 
complex matrices, determination of partition coefficients, and isolation of target compounds. One 
such application of LLE is for octanol-water partition coefficient (log Kow) determination. Log Kow 
(often reported as Kow, log K, or log P) is routinely used in both drug development to estimate 
bioavailability of pharmaceuticals,194–196 and in environmental studies to better understand 
aqueous remediation techniques.197 The most accurate and reliable method for determination of 
log Kow is the shake-flask method.
198 Similar to many other commonly used LLE techniques, the 
shake-flask method has large volume requirements (mL), long procedures (hours), and remains 
difficult to automate.178,199 In this work, we describe a microfluidic chip interfaced with an 
autosampler and UV-absorbance detector for rapid and automated LLE and apply it to log Kow 
determinations using microliters of sample. 
Microfluidic tools have been applied to miniaturizing LLEs for numerous applications. 
Parallel flow is a continuous microfluidic LLE technique in which two immiscible streams are co-
flowed forming an extraction interface.200 Several variations have been reported, demonstrating 
extractions from biological,201,202 environmental,203 and other complex matrices;204,205 however, 




extractable analytes.201,206 Additionally, longitudinal sample diffusion in these methods limit 
sequential analysis of different samples and must be accounted for when determining extraction 
coefficients.202  
The use of slug flow (also known as segmented flow) or droplet microfluidics has enabled 
many high throughput applications and has been shown as a viable alternative to conventional 
continuous flow microfluidics by limiting diffusion and increasing sample introduction rates.71 
Individual samples may be encapsulated in fL - nL aqueous plugs or droplets and processed 
discretely.207 Sample plugs or droplets experience internal mixing due to shear forces with the 
channel or tubing walls, which can be beneficial when applied to microfluidic LLEs.208 Segmented 
flow LLEs, in which aqueous plugs are segmented by an extraction phase, have been shown for a 
variety of applications including the study of mass transfer,171,208,209 preconcentration,210 sample 
preparation,86,211 and continuous synthesis.212 However, the demonstrated segmented flow 
techniques are not easily applied to high-throughput screening (HTS) applications. Automation 
and rapid sample introduction remain difficult to integrate into LLE microfluidic devices,71 and 
“cross-talk” due to phase interactions inhibit screening discrete samples once introduced to the 
microfluidic device.86  
Recently, our group demonstrated slug flow nanoextraction (SFNE) in which 5 nL plugs 
of extraction phase and aqueous sample are juxtaposed in a line of microfluidic tubing to form 
extraction “phase pairs.”213 The extractions occur in-line due to rapid mixing from internal 
recirculation within each droplet as the phase pairs flow towards a detector (UV, fluorescence, 
mass spectrometry). In droplet microfluidics, the use of a fluorinated oil continuous phase allows 
for chemical containment and low cross-talk between samples.214 Phase pairs were generated by 




and fluorous carrier fluid. The use of a fluorinated liquid spacer between phase pairs reduces cross-
talk that inhibits SFNE and other plug-based approaches. Internal recirculation of the individual 
aqueous and organic plugs expedites extraction due to the constant refreshing of the extraction 
interface, demonstrating improvements to extraction speed over parallel flow approaches.206 SFNE 
was shown for in-line sample cleanup of biofluids for analysis by mass spectrometry (MS) and for 
log Kow determination.
213  
A miniaturized, automated method for rapid determination of log Kow values could be 
useful in a pharmaceutical environment, where large compound libraries are generated, and 
determination of physiochemical characteristics are important at early stages where material is 
limited. Chromatographic methods have been used to automate log Kow screening; however, these 
methods often approximate log Kow based on calibration curves using compounds with known log 
Kow.
175,177 Additionally, chromatographic methods are limited in analyte scope and are relatively 
low throughput. Though the SFNE method previously described achieved miniaturized log Kow 
determination, its overall throughput is limited by the initial sipper step and the need to move 
tubing of sample from droplet formation to detector flow systems.213  
Here, we address previous limitations with a fully automated, online system for the rapid 
determination of pharmaceutical log Kow values using SFNE. A microfluidic device was designed 
for the generation of SFNE phase pairs in the first three-liquid-phase microfluidic system. 
Liquid/liquid/gas systems are commonly reported, but the gas results in high interference signals 
during detection and inconsistent flow due to compression. The microfluidic device is coupled to 
a liquid chromatography autosampler for the rapid introduction of low volume samples (< 20 µL) 
from a well plate, allowing for a user-friendly system for the rapid determination of log Kow values 




be further improved with newer or faster autosamplers. The device can rapidly switch between 
aqueous/perfluorodecalin (PFD) slug (aq droplets) generation and aqueous/octanol/PFD phase pair 
generation, allowing for rapid, online calibration curve generation (aq droplets) and unknown 
determination (phase pairs). The developed system is applied to screening a library of seven 
compounds at three pH values, resulting in 21 log Kow measurements in 2 hours, using only 5 µL 
of extraction standard and 2.9 µL of octanol per extraction standard measured. A subset of these 
results was validated by the microshake-flask method.191,215 The automated SFNE method reduces 
preparation and analysis time by 10-fold and sample/extraction phase volume requirements by 40-
fold compared to microshake-flask method adapted for this study. 
Materials and Methods 
 
 Reagents and Materials. All chemicals and solvents were purchased from Sigma-Aldrich 
(St. Louis, MO) unless stated otherwise. PFD was purchased from Oakwood Chemical (Colombia 
Hwy, Estill, SC). Drug compounds were prepared in HPLC-grade water and 1-octanol at 1-10 mM 
(for compounds requiring calibrations), aliquoted, and stored at -80 °C. Standards were thawed 
daily for use and diluted to the desired concentration. For droplet visualization, dyes were diluted 
to an arbitrary concentration with strong visibility and used for experimentation. The red dye 
mixture used in some experiments consisted of equal parts rhodamine B, methyl orange, 
erythrosine B, phenol red, and neutral red. 
 Device Design and Fabrication. Microfluidic devices were designed using Autodesk Inc. 
AutoCAD software (San Rafael, CA) and printed onto a Fineline Imaging transparency (Colorado 
Springs, CO). Microfluidic master molds were generated with 150 µm feature height using 
standard photolithography procedures; SU8 2075 negative epoxy photoresist was spun onto silicon 




the transparent mask, and developed to leave polymerized features. Curbell Plastics 
Polydimethylsiloxane (PDMS) (Livonia, MI) was prepared 1:10 activator to monomer ratio, 
degassed, and poured over the SU8 master. Fluidic ports were produced in the PDMS stamps. 
PDMS stamps fabricated with fluidic channels were bound to either glass slides (PDMS/glass 
devices) or to PDMS slabs (PDMS/PDMS devices) using oxygen plasma activation generated by 
a Harrick Plasma Inc. PDC-32G (Ithaca, NY). Microfluidic devices were flushed with 2% 
tridecafluoro-1,1,2,2-tetrahydrooctyl tricholorosilane in PFD for surface treatment.  
 Device Operation and Phase Pair Generation. All flow was applied using Hamilton 
(Reno, NV) gastight syringes (250 µL, 500 µL, 1 mL) with Chemyx Inc. Fusion 400 syringe 
pumps. Syringes filled with octanol, PFD, and water (or aqueous sample) were connected to their 
respective fluidic ports of the phase pair generator via 150 inner diameter (i.d.) by 360 outer 
diameter (o.d.) fused silica capillary coated with polyimide from Polymicro Technologies 
(Phoenix, AZ). Connections were made using low dead volume unions from Valco Instruments 
Co., Inc. (Houston, TX). For two-phase slug generation, 2.0 and 1.5 µL/min flow rates were 
applied for aqueous and PFD, respectively, unless stated otherwise. For three-phase slug 
generation (phase pairs), 2.0, 2.0, and 1.5 µL/min flow rates were applied for aqueous, octanol, 
and PFD, respectively, unless stated otherwise. Phase pairs (or droplets for two-phase) are 
segmented from one another as they reach the continuous PFD flow in the device, discretizing 
individual samples or extractions. These are exported from the device using 100 µm i.d. x 360 o.d. 
PFA tubing from IDEX (Lake Forest, IL) or fused silica capillary, which is also positioned within 
an online UV detector. UV detection used a Linear (Auburn, CA) UVIS 200 variable wavelength 
absorbance detector or a Linear UVIS 205 variable wavelength absorbance detector slotted for 




assessed. National Instruments (Austin, TX) LabView UV data acquisition software was used for 
UV absorbance data acquisition and analysis. The UV system had a maximum and minimum signal 
response at 1.1 and -1.1 V, respectively, corresponding in a cut-off signal in some traces. 
 For automation, the device is interfaced to a Thermo Fisher Scientific (Waltham, MA) 
UltiMate 3000 Autosampler using a Thermo Fisher Scientific 1 µL nanoViper sample loop. A 
syringe pump was interfaced to the six-port valve for aqueous flow. This flow acted as the 
water/aqueous flow during device operation. Injection and wash parameters optimized to provide 
frequent injections for HTS, where final settings are described in results and discussion. In initial 
experiments, standards were injected from 100 µL of solution in polypropylene autosampler vials. 
For HTS, standards were injected from 20 µL of solution in a 96-microwell plate. 
For validation of the HTS via microshake-flask method, offline extractions were 
performed, and each phase was injected using the LC autosampler through the UV detector. The 
microshake-flask method was performed by placing 500 µL of aqueous extraction standard and 
500 µL of octanol in vial, shaking for 60 min, and centrifuging for 10 min. Both phases were 
pipetted into an autosampler vial and injected for UV analysis with calibration curves in the 
aqueous phase. 
 A camera and microscope were often used to capture video of slug formation and export 
during experiments. For this, an AmScope (Irvine, CA) MU500 camera was positioned onto an 
AmScope microscope to capture video of slugs forming or being exported before going to the 
online UV detector. Video was captured using AmScope 3.7 digital camera software and edited 
using NIH (Bethesda, MD) ImageJ software. High resolution images and videos were taken using 
a Phantom Miro C110 (Wayne, NJ) on a Nikon (Tokyo, Japan) TS100 inverted microscope and 




Results and Discussion 
 
 Device Characteristic and Features. Phase pair generation is achieved by flowing 
the three phases into a PDMS device designed similar to a standard two-reagent droplet generation 
by flow focusing, where aqueous flow enters from the LC autosampler (Figure 5-1).71 In the 
device, equal volumes of aqueous and organic (sample and extraction phases, respectively) are 
segmented into phase pairs by the fluorous phase. Extractions occur at the interface between the 
organic and aqueous phases as they flow through capillary to the detector.  
Though the online SFNE generation 
device allows for rapid extraction times and 
minute volumes, rapid introduction of 
different samples remains challenging. To 
overcome this challenge, the phase pair 
generator was interfaced with an 
autosampler at the inlet which allows for 
various samples to be injected into a 
continuous aqueous stream from a sample array without stopping flow (Figure 5-2). In this format, 
throughput is only limited to how frequently samples can be injected using the autosampler and 
the preparation time of calibration/extraction standards. To maximize injection frequency, several 
key autosampler parameters were adjusted including sample loading parameters (draw speed, 
dispense speed, inter-step delays, injection volume), wash settings (wash speed, wash volume, 
inter-step delays), and injection loop settings (overfill factor, flush volume, loop volume). By 
maximizing most draw rates and dispense rates during sample loading and washing and 
minimizing most delays, an injection cycle of 78 s was achieved. Suitable flow rates were selected 
Figure 5-1. Automated log Kow determination using slug flow 
nanoextraction. Compounds are aliquoted into a well-plate and injected 
by an auto-sampler. A microfluidic device generates phase-pairs by 
segmenting sample and octanol with PFD. Aqueous and octanol phases 
are briefly co-flowed before segmentation by PFD. Phase pairs are 
exported parallel with the channel into tubing or capillary. An in-line 
UV detector is used for the analysis of analytes in both aqueous and 




to allow for baseline resolution of each injection and were set to a total flow rate through the device 
of 3.5 µL/min for aqueous droplet generation and 5.5 µL/min for phase pair generation. The 
injection frequency is the limiting factor to throughput using this autosampler,216 faster/newer 
technology would enable higher throughputs for log Kow determination.
217–219  
In an example of the online SFNE method, phase pairs were continuously generated, 
exported into capillary, (Figure 5-3A) and analyzed using in-line UV detection of red dye in each 
phase (Figure 5-3B). In a six-minute window of continuous generation and online UV analysis, 
194 replicate extractions were performed (0.5 Hz) reproducibly with a relative standard deviation 






Figure 5-2.  Complete online, automated system for SFNE. The autosampler can be loaded with a vial holder or a microwell plate from which 
calibration and extraction standards can be injected (through the 6-port valve). This allows for the device to be connected to the 6-port valve 
with continually flowing aqueous phase and various samples/standards to be introduced into the continuous aqueous phase. The device is then 




observed corresponding to PFD at baseline and different concentrations of dye in each phase at 
equilibrium (Figure 5-3B). The ability to continuously and reproducibly generate phase pairs, 
extractions, and analysis in this online system is crucial to successfully implementing the system 
for automated, serial extractions of different samples.  
Phase pair generation is dependent on the flow of three different phases. Relative flow rates 
into the generation device are responsible for the phase pair volume, aqueous to organic volume 
ratio, overall flow rate, and potential throughput in this system. Controlling the flow rates of each 
phase modulates both throughput and volume ratios of phase pairs and enables rapid switches 
between aqueous droplet generation and phase pair generation. As reported in the original SFNE 
method,213 manipulation of the volume ratio in phase pairs allows for preconcentration or dilution 
during extraction. Using the online generation device, the volume ratio (VR), 
Figure 5-3. Online SFNE generation and detection. (A) A mixture of red dyes (aqueous, 3) and extraction phase (octanol, 2) are segmented 
into 8 nL phase pairs by PFD (fluorous, 1). (B) Continuous online UV Vis detection of the phase pairs in Teflon tubing for an extended period. 




VR = Vorg/Vaq       
of the phase pairs can be adjusted by changing 
relative flow rates (Figure 5-4). For example, 
when using flow rates of 1.5, 1.0, and 0.8 
µL/min for PFD, octanol, and aqueous, 
respectively, a VR of ~0.75 was observed 
(Figure 5-4A). By adjusting the PFD, octanol, 
and aqueous flow rates to 0.6, 0.5, and 1.0 
µL/min, respectively, the VR was reduced by 
a factor of 2.2 to ~0.34 (Figure 5-4B).  
Though VR is not directly proportional 
to flow ratio (Floworg/Flowaq, FR), as 
demonstrated above (i.e. VR = 0.75 when  FR 
= 1.25, VR = 0.34 when FR = 0.5), 
preconcentration effects can be achieved 
through modulation of the FR. The online 
SFNE device was used to perform an 
extraction of 1 mM ACP with several different 
flow ratios to demonstrate preconcentration in 
this system through FR modulation (Figure 
3C). Reduction of the FR resulted in the increase of the final signal intensity in octanol, showing a 
2.6-fold increase in signal intensity when the ratio was reduced from 1.0 to 0.167 (Figure 5-4C). 
Figure 5-4. Volume manipulation via flow rate changes. (A) Similar 
flow rates result in near equal volume in the export tubing. (B) 
Increasing aqueous relative to organic flow rates reduced VR over 
two-fold. (C) Flow rate ratio was varied from 1.0 to 0.17 and signal 
intensity in octanol are reported. Signal increases as the flow ratio 
decreases, showing the effective preconcentration. At least 400 
replicates (equilibrium octanol plugs) were measured for each flow 
ratio. 


















































Based on a theoretical 
concentration curve as volume 
ratio is adjusted, ACP equilibrium 
concentration in octanol should 
increase by 150, 200, and 220% as 
VR is decreased from 1 to 0.5, 0.25, 
and 0.17, respectively (Figure 5-5). 
The signal intensity increased by 
160, 250, and 260% as FR was 
decreased from 1 to 0.5, 0.25, and 
0.17, respectively, reflecting a 
trend similar to that of the theoretical concentration curve. Theoretical concentrations in the 
extraction phase at equilibrium (Corg,eq) were determined by the following equation,  
𝐶𝑜𝑟𝑔,𝑒𝑞 = 𝐾𝐶𝑎𝑞,𝑒𝑞 =
𝐾𝐶𝑎𝑞,𝑖𝑛𝑖𝑡𝑖𝑎𝑙
1+𝐾𝑉𝑜/𝑉𝑎𝑞
    [4-1] 
where the octanol-water partition coefficient, K, is equal to 1.95 and the initial concentration in 
water (𝐶𝑎𝑞,𝑖𝑛𝑖𝑡𝑖𝑎𝑙) is equal to 1 mM. The theoretical curve is represented by the solid line. The 
squares represent the volume ratios for the flow ratios demonstrated in Figure 5-4. 
Phase Toggle and Calibration. Quantitative log Kow determination requires determining 
concentration in each phase. UV absorbance is a generalizable detector for measuring 
concentrations, but calibration is required for quantitative results. To overcome this challenge, the 
phase pair generation device was designed to allow for the organic flow to be readily toggled on 
and off. When organic flow is off, a segmented flow of aqueous solution and PFD is formed. When 
Figure 5-5: Theoretical concentrations for acetaminophen (initial concentration in 
aqueous of 1 mM) as volume ratio is adjusted to achieve preconcentration. Values were 
obtained through calculation using Equation 4-1. The theoretical curve is represented by 
the solid line. The squares are the mirrors volume ratios for the flow ratios demonstrated 




organic flow is on, phase pair 
generation occurs where extractions 
can occur during transit. This feature 
allows for single phase calibrations in 
water and multi-phase extractions to 
occur, enabling quantitative 
determination of unknown 
equilibrium concentrations without 
disassembly of the system 
components or an additional 
microfluidic device. The system 
adapts from aqueous droplet 
generation to phase pair generation in 
under five seconds after toggling the 
organic phase, providing rapid 
switching between calibration and 
unknown determination modes in an entirely online system (Figure 5-6) Calibrations were 
performed by sequential injection of five or six different concentration levels while in aqueous 
droplet generation mode. Unknown determination was performed by injecting a known 
concentration (1 mM, 10 mM) while in phase pair generation mode and measuring the resulting 
equilibrium concentration in water. 
Automated Log Kow Measurements. The autosampler interface and the organic flow 
toggle feature allow for automated injection of aqueous calibration standards followed by 
Figure 5-6. Images from a video where organic phase is toggle off and on every 
10 s. Phase toggling rapidly and reliably equilibrates in the microfluidic device 
between generating three phase “phase pairs” and two phase droplets when the 
organic phase is toggled on or off. (A) Snapshot of the device just before the 
organic (octanol) flow is toggled off. Phase pairs are being reliable generated here. 
(B) Snapshot of the device ~four seconds after the organic has been toggled off, 




injections of extraction standards and in-line extractions to occur in one system. This method was 
used in a demonstration to determine the log Kow of a test compound (acetaminophen, ACP) with 
an online and automated method (Figure 5-7A). Six aqueous calibration standards ranging from 
0.1 – 1.0 mM in water as well as a blank were injected, followed by triplicate injection of the 
extraction standard (1 mM ACP in water). The detector was zeroed using PFD. Differences in 
refractive indices resulted in a negative value for absorbance of ACP in water and octanol at some 
concentrations. During the injection of all calibration standards, the organic (octanol) pump was 
Figure 5-7. Full LC-SFNE-UV workflow. (A) In a single automated run, a calibration in water was performed followed by triplicate injections 
with SFNE to determine log Kow for acetaminophen. (B) Expansion of a portion of the trace, showing examples of the phase pairs that were 
used to determine equilibrium concentrations of acetaminophen in water post-extraction. (C) Value comparisons and validations in this study 
for online SFNE by comparison to previous reports, microshake-flask (aq,oct), and microshake-flask (aq only) log Kow values for ACP. 




programmed to switch off and aqueous droplets were generated for the calibration standards. For 
the injection of the extraction standard, the organic pump was programmed to switch on and phase 
pairs were generated for extractions between octanol and water. The aqueous portion of the phase 
pairs were selected from the leveled top of each injection and used for quantification (Figure 5-
7B).  
Using the six-point calibration to determine the equilibrium concentration of ACP in the 
aqueous layer of the phase pairs, the log Kow could be determined using equation 2: 
log Kow = log (Coct,eq/Caq,eq)     
Since the extraction uses equal volumes of octanol and aqueous sample for each phase pair, along 
with known extraction standard concentrations, Coct,eq can be calculated once Caq,eq is known, 
where 
Coct,eq  = Cinital - Caq,eq      
The log Kow determined by SFNE (0.28 ± 0.01) is comparable to previously reported values 
and the values190,191,194,220 determined by the microshake-flask method. Log Kow was determined 
by the microshake-flask method twice, once using calibrations in both octanol and water with 
direct measurements of each extraction layer to determine Coct,eq and Caq,eq (log Kow = 0.28 ± 0.01) 
and once using only an aqueous calibration and measurement of the aqueous extraction layer, using 
Equation 3 to calculate Coct,eq (log Kow 0.31 ± 0.005). The error between these two modes of 
determining log Kow using the microshake-flask method is minimal (6%), indicating that SFNE 
determinations can use aqueous-only measurements to accurately determine log Kow, doubling the 
throughput. The log Kow determined by online SFNE demonstrates suitable accuracy, as it fits 































































microshake-flask determined log Kow. The good linearity of the calibration suggested that fewer 
points could be used to increase throughput. Therefore, further log Kow determination applications 
of this method only use five concentration levels (one of which is a blank) and single extraction 
standard injections, as each extraction standard injection generates several quantifiable phase pairs 
since multiple phase pairs are compartmentalized during injecting (Figure 5-7B). 
Rapid Log Kow Determination. The developed system was applied to a determining log 
Kow for an array of compounds and conditions. Injections were performed from 20 µL of each 
standard in 96-microwell plate that contained a total of seven pharmaceutical compounds at three 
pHs (pH 3, 7.4, and 10) and their corresponding five-point calibration standards. The compounds 
were injected at both 1 mM and 10 mM for each condition to increase the range of measurable log 
Kow, as 1 mM standards are more likely below the calibration range at partition equilibrium if log 
Kow > 1.5. The octanol syringe pump was programmed to automatically switch between calibration 
and log Kow determination modes. An exemplary trace of a compound in the screen, eserine, is 
shown in Figure 5-8. Octanol flow was automatically turned on at approximately 57 min, following 
the final calibration standard. The standard curve demonstrates excellent linearity (Figure 5-8B). 
Figure 5-8. (A) Example trace of eserine from full log Kow screen. A five-point aqueous calibration curve in water was injected and generated 
into aq slugs. Organic (octanol) flow was started at 57 minutes. Unknown determination traces of eserine at pHs 3, 7.4, and 10, at both 1 and 
10 mM concentrations. Organic flow was stopped at 65 min in preparation for the next compound screen. (B) Calibration curve generated from 




After injection of the compounds at each of 
the pH levels, octanol flow automatically 
stopped (approximately 65 minutes) to 
allow for the standards of the next 
compound to be analyzed. Blank buffer 
injections were performed separately for 
baseline subtractions (Figure 5-9).  
The entire well plate was screened 
using the automated system in under 2 h, 
consuming 5 µL of extraction standard and 
2.9 µL of octanol per extraction standard 
analyzed (Figure 5-10), with all extractions 
reaching equilibration in-transit after 
injection. From the seven compounds 
Figure 5-9. Triplicate injections of blank buffer used for extractions 
standards at each pH during log Kow determination at (A) 214 nm and (B) 
254 nm. The average of the signal intensity for each pH was subtracted 
from the corresponding extraction standards when measuring Caq,eq. 
Figure 641 5-9: Blank buffer injections for quantification 
Figure 5-10. Raw trace of entire 7 compound screen where each compound has Log Kow determined at 3 different biological pH’s (3, 7.4, 
and 10) with a 5 point aqueous calibration curve before extraction for quantification. All 21 Kows were measured in under 2 h of analysis 




screened at the three pH conditions, 18 log Kow values were successfully determined (Table 5-1). 
The three log Kow values that are unable to be measured in the screen (yohimbine pH 3, 
neostigmine pH 7.4 and 10) were due to insufficient sensitivity to measure the minimal amount of 
analyte (if any) that partitioned out of aqueous.  
To validate the accuracy of the screen, each log Kow at pH 7.4 was determined using the 
microshake-flask method (Figure 5-11). The method used for validation required substantially 
higher volumes (500 µL of extraction standard and octanol per extraction) and much longer 
equilibration times (1 h of shaking, 10 min of centrifugation).198 Additionally, for triplicate 
analysis of each microshake-flask extraction, three injections of each extraction standard were 
required; for SFNE, the segmentation of each injection into compartmentalized phase-pairs allows 




and shake flask values were observed with percent 
difference of 1.6%, 24%, 48%, 28%, 64%, and 
41% for ACP, Fexofenadine, caffeine, 
nicotinamide, eserine, and yohimbine, 
respectively. These changes are most likely 
attributed to the commonly reported deviations of 
analyte degradation in the shake flask method due 
to long shake times at room temperature in ambient 
light,221 and preparation of calibrations in buffer 
(shake flask method) versus baseline subtraction 
(SFNE method). Degradation during shake-flask procedures is likely the major source of error. 
This was validated experimentally, where all target compounds were shaken (following 
microshake-flask procedures) for zero, one, and two hours and the corresponding changes in signal 
intensity were measured by direct UV detection (Figure 5-12). In this experiment, significant 
changes in signal intensity were observed in response to increased shake times for several 
compounds, suggesting impactful degradation. For example, eserine, which displays the largest 
error between shake-flask and SFNE (64%), saw a 59% change in signal after shaking for 1 hour, 
and 120% after 2 hours. The limited sample preparation and rapid analysis times associated with 
online SFNE has potential to determine more accurate log Kow values by avoiding degradation of 
target compounds.  
One notable test compound was yohimbine, which demonstrates significantly different 
partitioning across the pH ranges tested (Table 5-1). Yohimbine has multiple ionizable groups 
including both basic and acidic moieties. The pKas are 7.6 and 14.7, indicating that at the lowest 
Figure 5-11. A comparison of the log Kow determined at pH 7.4 




pH the compound is cationic, limiting its extraction into octanol. Upon raising the pH, the 
compound is neutral, allowing for octanol extraction. Additionally, fexofenadine appears to be 
more lipophilic in acidic environments, possibly due to its cationic charge shielded by large steric 
effects, but more hydrophilic when on the surface acid group is charged (pH 7.4 and 10). These 
variations in the log Kow may be of interest for understanding the bioavailability in both basic and 
acidic regions of the body such as absorption through the acidic stomach versus the more alkaline 
colon or small intestine.222,223  
 
Figure 5-12.  Samples were thawed to room temperature and sampled at 3 different time points during the shaking process (0h, 1h, and 
2h) and stored at -80C after sampling. These samples were then sequentially injected for online UV detection, where signal change was 
measured as a function of shake time. Though concentration change is not directly proportional to signal change since degradation 
products are not distinguished from initial analyte, change in signal intensity indicates degradation for most of these compounds during 
long shake times. Most notably eserine, which had a 64% difference in Kow determined by SFNE vs shakeflask, shows that signal 
intensity changes by 59% after 1 h of shaking. Degradation of analyte can increase or decrease the final Kow measured by direct UV 






A system has been developed using microfluidics and applied for rapid screening of 
octanol-water partition coefficients. In most existing online microfluidic extractions, aqueous 
sample continuously flows into the device allowing for frequent sampling; however, changing 
the incoming sample stream often requires stopping flow and/or manually swapping the sample, 
limiting many automated applications. To overcome this, an autosampler was interfaced with an 
extraction phase pair generation device and in-line UV absorbance detection for automated 
screening. The set-up allowed for seven compounds to be screened for log Kow values at three 
pHs each in under one hour including calibration curves for each compound, allowing for direct 
and accurate quantitation of partition coefficients using 5 µL of extraction standard and 2.9 µL of 
octanol per extraction standard analyzed. This system has several limitations, primarily 
associated with the UV detection. Though exceptional for in-line use and small volume analysis, 
capillary UV detection has poor sensitivity and linear range, ultimately limiting the method to 
use with high concentration chromophores. Possible solutions include use of alternative detectors 
such as mass spectrometry for label-free detection. Additionally, throughput could be further 
increased with newer/faster autosamplers, with injection cycles down to 22 s.217 In the future, 














Sensitive and High Throughput Screening for Directed Enzyme Evolution by Droplet-MS 
Introduction 
 Directed enzyme evolution is a rapidly growing field for the development of biocatalysts 
for synthetic reactions due to desirable enzymatic stereo- and regio-selectivity and potential for 
drastic improvements to yield and reaction rate.224,225 The workflow begins with diversification of 
a target gene and expression of that library to obtain a multitude of enzyme variants. Selection or 
screening is imposed to identify variants that offer improvements to the desired property (i.e. 
stereoselectivity, regioselectivity, reaction rate), and the corresponding genes are subjected to 
further rounds of mutation until a suitable biocatalyst is achieved.226  
 Though this process has potential to develop biocatalysts with unparalleled efficiency and 
selectivity for specific reactions, the directed evolution generates thousands of enzyme variants 
and subsequent reactions that need to be assessed. Screening these massive reaction libraries is 
typically regarded as the rate-limiting step in the directed enzyme evolution workflow.227 Much 
effort has been allotted to the development of innovative high throughput screening (HTS) 
techniques to expedite the analysis steps. Common HTS techniques applied for enzyme screening 
include fluorescence-activated cell sorting228 and microtiter plate activity-based assays.229–231 
Though having excellent high-throughput capabilities, these techniques are fluorometric or 
colorimetric assays and are subsequently limited in the variety of substrates and products that can 




including techniques such as analytical separations paired with UV detection232 and direct mass 
spectrometry (MS) approaches, where MS in particular has become an attractive tool for screening 
reaction libraries due to its wide variety of ionization techniques, label-free capabilities, and ability 
to interface with various sample loading/sample introduction assays.233 Direct MS has been paired 
with various sampling and ionization techniques for enzyme reaction screening including robotic 
sample loading with Agilent RapidFire,234 MALDI-MS from arrays of spotted enzyme 
reactions,235 droplet microfluidics with electrospray ionization (ESI),236 and acoustic-mist 
ionization directly from well plates.237 
 As mentioned above, droplet microfluidics, more specifically segmented flow, has been 
reported with ESI-MS for rapid screening of enzyme reactions from a well plate, allowing for 
label-free detection and rapid introduction of a sample array.236 In this previous study, enzyme 
variants are created and enzymatic reactions are carried out in multi-well plates. Using syringe 
pumps and Teflon tubing, droplets segmented from one another by an immiscible carrier fluid are 
generated directly from the wells in the well plates and infused into ESI-MS for HTS with sample 
introduction rates up to 3 Hz. Though this method shows excellent utility for label-free directed 
evolution HTS, the high flow rates used and the utilization of a diluting sheath-flow sprayer for 
ESI make this method unsuitable for low concentration measurements, especially from complex 
biological matrices. 
 In this work, we develop a droplet-nESI-MS/MS method to achieve a sensitive, high 
throughput method with application for HTS as a cytochrome P450 is evolved for increased 
biocatalytic activity for a biaryl coupling reaction. Biaryl scaffolds are present in many different 
natural products that are known to offer efficacy as therapeutics in both modern drug development 




as significant quantities remain challenging to obtain synthetically.240 To develop a synthetic route 
for the biaryl coupling of C5-methyl coumarin and 2-napthol with substantial yields, a cytochrome 
P450, a class of enzymes which has been previously identified as a catalyst in biosynthetic biaryl 
coupling,241,242 is evolved for increased activity. The HTS method developed in this work utilizes 
several features to obtain sufficient product LODs for the low initial activity in this reaction. 
Using nESI and high dilution factors, limits of detection (LOD) for the reaction product 
down to 12 nM and a linear dynamic range from 0.025 to 25 µM. High levels of ionization 
suppression are expected by ESI. Several steps are taken during method development to combat 
suppression, including implementation of nESI, dilution, organic modifier addition, and use of an 
internal standard (IS). The developed method is compared to a standard LC-MS method (3 min 
analysis time) for screening a single reaction plate (96 enzyme reactions). The method is finally 
applied for HTS of an entire library comprised of 1,728 reactions, where 1,512 of the reactions are 
different enzyme variants and 216 are either positive wild type (WT) or no enzyme (-) controls. 
During screening, sample introduction rates up to 2.4 s per sample are achieved, where each 96-
multiwell plate is screened – in triplicate – within 16 min, whereas triplicate screening of one plate 
by LC-MS takes over 14 h. Statistically significant “hits” are selected that show higher enzymatic 
activity than WT controls. Seven hits are identified. 
Materials and Methods 
Reagents and Materials. All chemicals and solvents were purchased from Sigma-Aldrich 
(St. Louis, MO) unless stated otherwise. Perfluorodecalin (PFD) was purchased from Oakwood 
Chemical (Colombia Hwy, Estill, SC). Calibration standard mixtures were prepared by dissolving 
standards directly in blank reaction matrix at 250 µM, which were aliquoted and stored at -20 ⁰C. 




of substrates. Aliquots of calibration standards brought to room temperature daily before use and 
spiked with 50 µM acetaminophen (ACP) dissolved in HPLC-grade water to a final concentration 
of 5 µM as the internal standard (IS). 
Droplet Generation. Hamilton (Reno, NV) gastight syringes were used (25 µL) with a 
Harvard Apparatus PHD 2000 programmable syringe pump for droplet generation. Enzyme 
reaction mixtures were received in 96-well plates and were transferred to 384-well plates for 
droplet generation using micropipettes (35 µL aliquots from each reaction). 384-well plates were 
divided into four sections via epoxy walls: three 96-well sections (6 x 16 wells) and a calibration 
standard section (7 x 1 wells). Walls were formed by depositing several layers of epoxy along the 
outside of each section. Once the reaction mixtures were transferred to the 384-well plate, inert 
fluorous carrier fluid, PFD, was gently pipetted over the filled wells up to the height of the epoxy 
walls. Droplets were generated using a syringe pump drawing rate of 700 nL/min with a 25 µL 
syringe attached to 40 cm of 150 µm inner diameter (i.d.) by 360 outer diameter (o.d.) PFA tubing 
from IDEX (Lake Forest, IL). Connections were made using low dead volume unions from Valco 
Instruments Co., Inc. (Houston, TX). Droplet generation was performed using an XYZ-position 
manipulator to draw from the 384-well plate, as previously described. The positioner was used to 
alternate the tubing between PFD (0.2 s draw) and sample (0.8 s draw) until the line was filled 
with three droplets from each reaction mixture, totaling 288 droplets per generation cycle (96 
reactions per analysis, 5 – 10 nL droplets). For calibrations, five droplets for each of the seven 
concentration levels were generated, where calibration levels can be seen in Figure 6-4. 
Droplet-nESI-MS/MS. Syringes and attached droplet trains were used with Chemyx Inc. 
Fusion 400 syringe pumps for direct droplet infusion. Seven point calibrations were infused at the 




For calibrations and reaction screening, droplets are infused at 0.5 µL/min using platinum-coated 
30 µM i.d. spray tips from New Objective (Littleton, MA) at 2 kV, with a drying gas set to 150 
L/h. All mass spectrometry was performed on a Micromass Quattro Ultima triple-quadrupole mass 
spectrometer (Waters, Milford, MA). Tandem mass spectrometry (MS/MS) was used for all 
experiments in single reaction monitoring mode (SRM) to monitor all mass transitions 
simultaneously. The mass transitions (parent ion → daughter ion m/z), collision energy, and dwell 
times used for each compounds are as follows: C5-methyl coumarin (Sub A, 177 → 77.1, 30 V, 
30 ms), cross product AB (319.1 → 115, 30 V, 50 ms), and ACP (156 → 110.1, 15 V, 30 ms). LC-
MS comparison/validation was performed an Agilent 1290 Infinity Series II LC UHPLC system 
using a Waters Acquity UPLC HSS TS 1.8 µm C18 2.1 x 50 mm column interfaced to an Agilent 
6230 TOF MS with a  Dual AJS ESI source. 
Data Analysis. Data collected by MS is comprised of droplet MS/MS traces for SubA, 
AB, and IS, where several points of signal are obtained for a droplet before signal returns to 
baseline as non-conductive PFD reaches the spray tip. Microsoft Excel is used for most data 
analysis, where the raw points for each trace (time, ion count) are used. Droplets are identified in 
a trace using “IF” functions to identify when droplet signals start and end, where any points higher 
than the PFD noise threshold are selected and extracted into a different column. Each set of 
extracted points are averaged across the middle (shoulder points excluded), and the subsequent 
values are used as the signal intensity of a given droplet, where 288 droplets are expected per plate 
screened. However, since reaction mixtures contain 50% MeOH, droplet splitting is a common 
phenomenon from lack of surface tension, which results in higher than expected droplet quantities 
in the subsequent readout. Several steps were taken to overcome this including “COUNT” 




step (as was droplet selection, extraction, and averaging) to eliminate small pieces of droplets that 
break off from the main droplet. COUNT functions in tandem with “IF, AND” functions allow 
points across a droplet to be averaged only if they meet a quantity threshold (e.g. point clusters 
less than 4 points would not be counted as a droplet). Though COUNT elimination often resolved 
splitting issues in data analysis, occasionally they would eliminate entire droplets from a trace, and 
the readout would report fewer droplets than what was infused. To speed up the location and 
identification of these splitting issues, evenly spaced RESET droplets were added to infusion 
experiments. A RESET droplet is a long droplet (~20-30 nL) that occurs after ever row of reactions 
(six reactions, in triplicate, 18 droplets). During droplet selection in Excel, a COUNT function is 
added to identify RESET droplets based on droplets that exceed a quantity threshold (e.g. more 
than 20 points are identified as RESETs). In the final list of droplets from 96-well plate screen, 
droplets can be easily assigned to their corresponding wells based on which number RESET 
droplet they come after/before, and droplet quantities not equal to 18 between two RESET droplets 
can be quickly identified and corrected. 
Internal standardization is implemented to improve accuracy and reproducibility of results 
by mirroring nESI changes caused by matrix effects or electrospray fluctuations. This is especially 
useful, as the present of high concentration 2-napthol drastically effects ionization (See Results 
and Discussion). During data analysis, signal response is reported as a ratio of analyte signal 
intensity divided by IS signal intensity (S/IS). The results for each reaction screened are reported 
as relative conversion to AB (percent of Sub A converted to cross product AB). Relative 
conversion is defined using the following equation: 
















Where [A] and [AB] are the concentrations of SubA and AB after the reaction, respectively. To 
standardize the results obtained across each of the eighteen 96-well plates screened in this study, 
each plate is normalized so that relative conversion of the average WT reaction is equal to 1. This 
normalization allows for the data shown to also represent fold-improvement (y-axis) over the 
conversion from the WT reactions for each well (x-axis). Hit identification carried out using 
standard T-Test in GraphPad Prism to define P values, where P values less than 0.05 are defined 
as statistically significant hits 
KtnC Variant Library Generation. Using a homology model generated of KtnC 
(generated using Phyre 2.0 software and modeled after PDB 4LXJ), 96 residues within 12 Å of the 
predicted substrate binding region were selected. Blunt-end degenerate codon (NNK) primers were 
designed for the incorporation of a random mutation at each of the selected positions and ordered 
from Integrated DNA Technologies (Coralville, IA). Site saturated mutagenesis (SSM) 
polymerous chain reactions (PCRs) were performed in 96-well plates with 25 μL reaction volumes 
containing 1X HF Phusion buffer, 4% DMSO, 0.4 mM dNTPs, 0.8 μM of each the forward 
degenerate and reverse primers, 10 units of Phusion DNA polymerase, and 2.5 ng pESC-
HIS::KtnC template plasmid. The reaction conditions were programmed as follows: 98 °C 
denaturation for 2 min; 25 cycles of 98 °C for 20 sec, 56 °C for 20 sec, 72 °C for 4.5 min; and a 
final 72 °C extension for 10 min. PCR products resulting from each of the 96 different primer pairs 
were pooled and concentrated by ethanol precipitation. The combined and concentrated PCR 
products were extracted from a 0.8% agarose gel. Wild-type template DNA was digestion in a 
reaction containing 1X Cutsmart buffer from New England Biolabs (NEB, Ipswich, MA )and 60 
units of DpnI that was incubated at 37 ˚C overnight. DNA was cleaned using a Qiagen (Hilden, 




kinase (PNK) in 1X T4 DNA ligase buffer (NEB). After 30-min incubation of the phosphorylation 
reaction at 37 ˚C, 400 units of T4 DNA ligase were added directly to the reaction. The ligation 
reaction was incubated at 16 ˚C overnight before the DNA was cleaned using a Qiagen spin 
column. DH5α competent E. coli cells (NEB) were transformed with the ligated DNA using 
standard electroporation protocols before the cells were plated on luria broth (LB) agar plates. E. 
coli colonies were cultured and miniprepped to provide the mutated DNA library. S. cerevisiae 
cells could then be transformed with this DNA library using a standard protocol for lithium acetate 
transformations. Transformed cells were plated on histidine dropout plates containing 2% glucose 
and incubated at 25 °C for 3 days. 
KtnC Library Reactions. The KtnC variant library was reacted in high-throughput 
biotransformations in S. cerevisiae cells. Histidine dropout minimal media (800 μL, 2% glucose) 
was added to each well of a 96-well culture plate (2-mL capacity, VWR International, Radnor, 
PA). To inoculate the cultures, 84 wells were each inoculated with a single colony from an agar 
plate containing the colonies each harboring a single mutated ktnC gene, ten wells were inoculated 
with control cells harboring the wild-type KtnC gene (WT), and two wells were left blank as 
negative controls. The cells were grown at 30 ˚C, 315 rpm for two days until all wells had reached 
saturation. The plate was centrifuged at 1,000 x g for 10 min to pellet the uninduced cells and the 
growth media was decanted. To induce expression and initiate the biotransformation, the cells 
were resuspended in 250 μL histidine dropout minimal media containing 6% galactose and the 
target substrates (250 μM 2-naphthol and 750 μM 7-hydroxy-5-methyl-2H-chromen-2-one). The 
biotransformations were incubated at 30 ˚C, 315 rpm for 3 days. To quench the reactions, 10 μL 
CelLytic™ Y Cell Lysis Reagent was added to each of the wells and incubated at 30 ˚C, 315 rpm 




H2O in that order. Samples were centrifuged and the supernatant was analyzed for product 
formation by MS or LC-MS. 
Results and Discussion 
 Method Development. Reactions received for screening in this work are comprised of cell 
lysis supernatant with high micromolar Substrate A (SubA) and millimolar Substrate B (SubB), 
both of which are relatively hydrophobic (Figure 6-1) and are expected to express high surface 
activity within electrospray droplets. Additionally, WT reactions are expected to achieve relatively 
low reaction yields with final concentrations of the cross product (AB) in the low nanomolar range. 
These conditions are predicted to cause substantial ionization suppression, so several steps are 
taken during method development to overcome suppression and improve LODs, including 
implementation of nESI, dilutions of the reaction mixture, addition of organic solvent (MeOH), 
and use of an IS. Implementation of nESI over ESI, as discussed in Chapter 1, can allow for 
improvements to ionization efficiency and reduction of ionization suppression, where small spray 
tip geometries and infusion rates of 1 nL/min can improve ionization efficiency over three orders 
of magnitude (Chapter 1). However, since this method is being implemented for HTS, 
compromises must be made between throughput and sensitivity, therefore a flow rate of 500 
nL/min with a 30 µm i.d. nESI emitter was initially selected. Higher flow rates would be beneficial 
for improving throughput, although even minor increases begin to affect the attainable LOD for 
Figure 6-1. Target reaction for work in Chapter 6 of biaryl coupling of C5-methyl coumarin and 2-napthol. HTS analysis targeted for 




AB, with an increase from 500 to 600 nL/min increasing the LOD by 67% based on calibration 
curves obtained for each flow rate on a given day. Therefore, 500 nL/min was maintained moving 
forward. Additionally, the final reaction mixture was composed of 50% MeOH (v/v) which most 
likely positively contributed to the AB LOD, as organic additives are known to assist with 
electrospray and can greatly improve LODs;243 however, further adjustments were not 
investigated, since droplets experience excess splitting at higher organic content from lack of 
surface tension. 
Another important condition we explore is the dilution factor (Figure 6-2). For the final 
step of the reaction, a 2-fold dilution of the reaction mixture with MeOH is required (1 part reaction 
mixture, 2 parts MeOH). For droplet generation stability and to avoid droplet splitting, higher 
water content is desired. Therefore, 2 parts water is added, bringing the final mixture to 50:50 
MeOH:water (v/v), having diluted the original reaction mixture 4-fold (1:4).  More dilution was 
investigated for potential to further minimize ionization suppression from the biological matrix 
Figure 6-2. Comparison of conditions that cause ionization suppression (matrix vs matrix with high concentration reaction substrates present) 
and two different dilution factors to overcome a degree of suppression. (Left) A demonstration of IS spraying from final reaction matrix diluted 
1:4 in diluent (50:50 MeOH:water, v/v) without substrates present. (Middle) IS spraying from final reaction matrix diluted 1:4 in diluent with 




and high substrate concentrations, where an additional 2 parts MeOH and 2 parts water were added, 
ending at an 8-fold dilution of the original reaction mixture (1:8). During this investigation, it was 
discovered that the matrix has a minor contribution to overall suppression compared to the high 
reactant concentration. In Figure 6-2, IS (5 µM ACP) was added to a blank final reaction matrix 
(no substrates present) and to a real final reaction matrix (substrates present). In this comparison, 
IS signal was 19-fold lower when substrates were present vs in the matrix alone without substrates 
present (1:4 dilution). Further dilution (1:8) allowed for significantly less ionization suppression, 
where IS signal was only 3-fold lower with substrate present than without. Despite reducing the 
final concentration of AB by 50% with the additional dilution, suppression was reduced 6.3-fold 
with the 1:8 dilution, allowing for significantly higher signal response. Additionally, ACP at 5 µM 
was selected as the IS because of its structural similarities to the analytes. Since the calibration 
standards experience substantially less ionization suppression than reaction plates, presence of 
ACP in each allows for more accurate measurements of AB and SubA as suppression differences 
are reflected in the IS. For example, for one of the plates screened in the study, AB concentrations 
were measured with and without the use of the IS for quantification (Figure 6-3). The 
concentrations of AB determined in each well was on average 4.7-fold lower without IS, as 
Figure 6-3. Cross product quantification from a screen with and without the use of internal standard. IS corresponds to 5 µM ACP which is 




suppression differences between the calibration and reaction screening are not accounted for, 
causing concentrations in the samples to appear lower when suppression is greater. 
Using the previously described reaction mixture and nESI conditions with a sensitive 
MS/MS mode of analysis, LODs down to 12 nM for AB were obtained using the limit of blank 
method to calculate LOD from a seven-point calibration curve (Figure 6-4A).244 To account for a 
potentially broad range of reaction yields, a calibration from 0.025 to 25.0 µM was used 
demonstrating linearity (R2 = 0.998) over a three-order of magnitude concentration range for SubA 
and AB. During calibrations, five droplets were infused at each concentration and the three middle 
droplets for each were used to generate a triplicate calibration curve in an infusion span of 1.5 min 
(Figure 6-4B). During calibration, standard droplets were introduced to nESI at a rate of 2.4 s per 
sample. 
LC-MS Comparison. Without special precautions, LC-MS methods for screening have 
throughputs of minutes (3 – 5 min) per sample.236 While LC-MS methods are robust and useful 
when front-end sample clean-up is necessary, 96 samples (a typical microwell plate reaction panel) 
will take approximately 14 h to screen. As a comparison, the developed droplet-nESI-MS/MS was 
Figure 6-4. (A) Seven-point calibration curve for AB with linearity (R2 = 0.998) from 25 µM to 25 nM. (B) Raw trace of calibration 
from droplet-nESI-MS/MS, where five droplets are sprayed from each concentration level, and the middle three of each level are 




applied to the screen a single MWP  (96 wells) of enzyme reactions in triplicate within 15 min of 
infusion, over 50-fold faster than the same screen run by LC-MS (Figure 6-5A). Triplicate analysis 
is performed by generating three droplets from each well in the MWP to be analyzed during 
infusion, where sample infusion occurs at 2.4 s per sample. The results obtained by the droplet-
MS screen were compared to the same reactions screened in singlet by LC-MS for validation, with 
the improvement over the WT reaction reported for each well for both methods (Figure 6-5B). To 
determine fold-improvement over WT, the relative conversion (% SubA conversion to AB) was 
determined for each reaction, and all conversions were multiplied by a normalization factor to 
bring the average relative conversion in the WT reactions equal to one. Most conversions 
determined by method were within reasonable error of one another, the average error between the 
two methods was 23% for all reactions with fold-improvements over 0.25. The most likely source 
of high error at the lower conversion is due to insufficient LODs from the LC-MS, as the LC-MS 
method is not specifically tuned for low LODs or extensive quantification. The LC-MS method 
used peak areas for quantification rather than calibration curves and concentrations, making the 
method only semi-quantitative. Eleven of the reactions screened in this comparison were even 
below the LOD for AB in the droplet-MS method (< 12 nM), also contributing to error at lower 
conversions. Nonetheless, if relative conversion determined by each method are placed in a 
comparison plot, good linearity (R2 = 0.83) and a slope near 1 is obtained, demonstrating the 
overall correlation between the two screening methods (Figure 6-5C). 
Full Library Droplet-MS HTS. Eighteen 96-well plates were screened in triplicate 
corresponding to 1,728 enzyme reactions or 5,184 individual samples. Though samples could be 
infused at a rate of 2.4 s/sample (under 20 min per triplicate 96-well plate), several factors limit 




PFD, time to generate droplets (~ 20 min), preparation and execution of calibrations, and potential 
trouble shooting (i.e. excessive droplet splitting or leaks in the well plates). After accounting for 
all time constraints, up to six plates were screened in triplicate in a single day (10 h/day), 
corresponding to 576 enzyme reactions or 1,728 individual samples and 33% of the entire library 
in a single day. This number of samples corresponds to nine days (10 h/day) of LC-MS screening, 
without accounting for any time constraining factors with LC-MS. The top 60 enzyme reactions 
with the highest relative conversion are plotted, where all plates are normalized so that WT = 1, 
so the y-axis effectively corresponds to fold-improvement over the WT enzyme, as well as adjusted 
relative conversion (Figure 6-6). Of the 1,728 enzyme variants screened, 21 variants showed 
Figure 6-5. (A) Example of entire plate (96 reactions) run in triplicate within 15 min, where the MS/MS trace for SubA is shown. 
Zooming in on one of the many sections is an example of the droplet data, where each cluster holds 18 droplets (6 wells in triplicate) 
and a final “reset” droplet. (B) Fold-improvement over WT reactions shown, where fold-improvement is based on improvement in 
conversion to AB. Error bars are shown for the triplicate measurements by droplet-MS but were not obtained for LC-MS for time 




higher conversion than average WT with up to 3.5-fold-improvement. Hits were selected using a 
t-test that accounts for various conditions including degree of improvement over WT, SD of WT 
reactions (averaged across all plates), and SD of the potential hit. Using this method, seven 
statistically significant hits were identified. These hits and other nearly hits were validated by LC-
MS, and the variant with the highest improvement over WT identified by LC-MS was selected for 
further evolution. 
Conclusions 
 MS is an excellent tool for screening enzyme catalyzed reactions in a directed evolution 
workflow as it is label-free, sensitive (compared to UV, colorimetric), structure elucidating, and 
can interface with various techniques/instruments. However, most MS screening approaches rely 
on LC-MS which is limited in its throughput. In this study, droplet microfluidics (segmented flow) 
has been paired with direct nESI-MS/MS for the first time to achieve a highly sensitive method 
(LOD = 12 nM) with sample introduction rates of 2.4 s per sample. This method was applied to 
screening a full enzyme variant library of 1,728 different reactions in triplicate, with up to 576 
reactions (1,728 samples) analyzed in a single day, where seven statistically significant hits were 
identified with up to 3.5-fold-improvement over WT reactions. Though this method sacrifices 
Figure 6-6. Top 60 reactions from 1,728 reaction screen. Seven statistically significant hits were identified (blue points/error bars), and 
most reactions analyzed have less than or equal to the relative conversion of the WT reaction. The WT reaction and its SD is shown by the 




faster sample introduction rates for improved sensitivity, this caveat has little impact on overall 
throughput. The major limitation on throughput in this screening procedure comes from the 
relatively long sample preparation/droplet generation times and restriction to finite volumes that 
can fit in the microfluidic tubing. Generally, a length of tubing can only fit enough droplets for a 
single 96-well plate (in triplicate), requiring regular manual swapping of tubing pieces between 
droplet infusion and generation. This limits the screening to ~576 reactions (in triplicate) in a 10 
hr workday, though this is still nearly 10-fold higher throughput than screening by a typical 3 min 



















Conclusions and Future Directions 
 In the previous chapters, various methods and systems have been developed to address 
common analytical limitations in throughput and sensitivity, generally in mass spectrometry-based 
systems. These include the development of a novel method and application using powerful EKS 
online preconcentration with CE-MS, high temporal resolution monitoring of seven 
neurochemicals using droplet microfluidics with direct MS, the first report of droplet-nESI for 
HTS in a directed enzyme evolution workflow, and development of a new form of online liquid-
liquid extraction. Though the work in this dissertation is diverse with projects including analytical 
separations, droplet microfluidics, or mass spectrometry (and often combinations of these), each 
project introduces a novel method for sample preparation or sample introduction to an analytical 
platform that pairs various analytical technologies in innovative ways. Droplet microfluidics (or 
segmented flow) is frequently utilized in these workflows in novel, advantageous, and innovative 
ways, and the under-represented field of droplet microfluidics paired with mass spectrometry is 
advanced in this work. Novel methods pairing these technologies has allowed for high throughput 
and sensitive sample introduction, achievements with high temporal resolution for many analytes 
simultaneously, and rapid microfluidic extractions for in-line sample clean-up. 
 The methods developed in previous chapters generally aim to improve throughputs and/or 
detection sensitivity for various technologies and applications. Though each of the platforms and 




adjusted for further improvements or alternative applications. Many of the platforms developed 
were tuned for either throughput or sensitivity, and optimization of one of these parameters is often 
sacrificed for the other. Examples include capillary CE-EKS-MS/MS, where extended 
injection/preconcentration times were applied to drastically improve limits of detection; or in 
droplet-nESI-MS/MS for neurochemical monitoring, where sufficient LODs were obtained for 
seven neurochemicals simultaneously through reduction of direct-MS infusion flow rates, though 
this substantially increased analysis times. In this chapter are several alternatives or improvements 
to the previously discussed  methods that could be developed to further advance the work presented 
in this thesis, including a proposed sheathless electrospray platform for EKS with CE-nESI-
MS/MS, “real-time” in vivo neurochemical monitoring, and online and continuous sample clean-
up using automated SFNE with MS.  
Future Directions 
Sheathless CE-MS Interface with EKS 
 
 The CE-EKS-MS/MS method in Chapter 2 interfaced CE with MS via a robust co-axial 
sheathflow sprayer. The sprayer establishes a ground to the migrating solution and assists the 
electrospray process by diluting CE eluent with an ESI friendly solution at a constant and relatively 
high flow rate as well as providing an assisting gas flow. This interface is one of few CE-MS 
interfaces that is commercially available and is well regarded for providing robust, grounded 
separations and interfacing.245 Though robust for CE-MS, sheathflow interfaces in general can 
significantly hinder detection sensitivity, as migrating compounds are diluted up to three orders of 
magnitude at the interface due to the highly contrasting flow rates of the electroosmotic flow and 




without additional dilution as a result of the minute injection volumes (pL - nL) associated with 
CE.110  
 Sheathless CE-MS interfaces are often used to gain addition detection sensitivity in CE-
MS methods, and studies have found that simply employing this type of interface can improve 
LODs over 5-fold compared to a sheathflow interface.52,104 Employing a sheathless interface with 
the CE-EKS-MS/MS platform could provide several improvements or alternative approaches to 
the method. If the majority of the original conditions used in the method were maintained while a 
sheathless interface were employed, nearly a 1000-fold dilution factor would be avoided which 
could drastically improve detection sensitivity with potential fM LODs (based on the original low 
pM LODs for various neurotransmitters). This improvement could allow for several changes to 
the existing method including trace analysis of neurotransmitters in different sample types (i.e. 
dialysate, plasma, etc.), addition of new target analytes (i.e. low concentration neuropeptides),246 
and could lead to reduction in volume requirements for EKS-based injections. Another route that 
could be taken while employing a sheathless interface with EKS is reduction of the injection 
duration/voltage and separation capillary length to offer faster separations. With the original 
method, long and powerful injections (150 s, 375 V/cm) are implemented , limiting the ultimate 
length of separation capillary remaining after injection to electrophoretically resolve target 
analytes. Theoretically, a shorter injection would increase the remaining separation capillary 
available after injection for CZE to occur and could result in (a) higher resolution/peak capacity 
or (b) allowance for a shorter separation capillary while maintaining the original resolution/peak 
capacity, and subsequently higher throughputs with similar LODs due to improvements by the 




 The proposed system consists of a separation capillary with a narrow ~10 µm i.d.) 
conductively coated (gold) nESI emitter directly integrated onto one end of the separation 
capillary, where the ground/electrospray voltage is applied to a stainless steel tubing that sheathes 
the emitter (Figure 7-1). In this set-up, the same capillary electrophoresis system used in Chapter 
2 can still be used, where the autosampler/power source are connected to the front-end of the 
separation capillary, the majority of the separation capillary is stored in the air-cooled holder, and 
the eluting end of the separation capillary is sheathed in the stainless steel tube and fixed to the 
nESI source. Using the Agilent 7100 CE System, pressure can be applied to achieve a constant 
flow rate in conjunction with the EOF. This may be an important feature for functionality of the 
proposed system, as the minimal bulk flow associated with the EOF in this high pH buffer system 
(~6 nL/min) may make it difficult to achieve robust spray and grounding with EOF alone.  
 Preliminary results were obtained to ensure the validity of the proposed platform. To 
prepare the spray tips, a Sutter Instrument Co. P-2000 capillary puller was used to evenly pull apart 
120 cm of  50 µm i.d. by 360 µm o.d. capillary, forming two 60 cm separation capillaries with  
approximately 10 µM i.d. tips, which were subsequently coated in gold using a Quorum 
Technologies SC7620 Mini Sputter Coater to obtain a conductive finish on the integrated nESI 
emitter (Figure 7-2). The resulting separation capillary with the integrated nESI emitter was 
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Figure 7-1. Sheathless CE-MS system for use with EKS, where the separation ground is applied by the slightly positive 
(compared to separation voltage) nESI voltage.  




placed, as demonstrated by Figure 7-1, with the front-end of the capillary positioned within the CE 
system and the nESI end affixed onto a stainless steel nESI platform on a Micromass Quattro 
Ultima triple quadrupole mass spectrometer.  
Extensive method development 
was not performed for preliminary 
experiments, and therefore the 
separation, nESI, and MS/MS 
parameters were not optimized for 
complete analysis. However, important 
observations were made on this 
assembly. A stable ground and separation current could be obtained for a reasonable duration of 
time corresponding to a relatively long electrophoretic separation (Figure 7-3A). Additionally, 
nESI was successfully performed on a set of test compounds including DA, NE, E, and Ch (Figure 
7-3B). 
 
Figure 7-3. (A) 21.5 kV of separation current was applied while connected to 1.5 kV of nESI voltage, totaling 20 kV across the separation 
capillary for 16 min, where a stable current was obtained over the period indicating stable ground and interfacing. (B) A solution of 1 
µM neurotransmitters dissolved in water were infused by applying pressure in the CE system to obtain a infusion rate of 100 nL/min, 
indicating that electrospray can be conducted using the home-pulled separation capillary-nESI system while maintaining stable spray.  
300 µm 
Figure 7-2. Image of the separation capillary back-end with a home-
pulled, gold-coated, integrated nESI emitter. The inner diameter of the 




Real-Time In Vivo Neurochemical Monitoring 
 
 While previous reports have shown low-second temporal resolution while monitoring one 
– four neurochemicals from microdialysate,24,98,142 LC-MS is required when more compounds are 
being monitored, typically raising the temporal resolution to 5 – 20 min. The method developed in 
Chapter 3 for high temporal resolution in vivo monitoring of neurochemicals improves temporal 
resolution compared to what could previously be obtained while monitoring many (seven here) 
neurochemicals simultaneously. Although robust, sensitive, and high throughput given the number 
of samples generated in a single in vivo collection (>1000 fractions per in vivo experiment) the 
method has one major limitation. Since the flow rate of direct-MS infusion is substantially lower 
than the flow rates during in vivo fraction collection/droplet generation (0.05 µL/min vs 1.0 
µL/min), analysis takes 20-times longer than collection, meaning 10 min of neurochemical 
monitoring takes 3 h to analyze by droplet-nESI-MS/MS. This limits the use of this method to 
fewer in vivo experiments in a day and/or to shorter time-spans of neurochemical monitoring. 
 To overcome this challenge, I propose a system for “real-time” monitoring where the in 
vivo sampling is flowed directly to the nESI-MS/MS for online analysis. To achieve this while 
maintaining low nM LODs and at most 10 s TR, the in vivo fraction collection/droplet generation 
platform used in Chapter 3 is largely left unchanged, where the MD probe perfusate and internal 
standard/diluent mixture merge in a microfluidic cross and are segmented into droplets by an inert 
fluorous carrier fluid (perfluorodecalin, PFD), but larger droplet fractions are generated. These 
droplets and corresponding flow rates are then split into two channels in a microfluidic device at 
a 1:20 ratio, one which takes a bulk of the flow and droplet volume (0.95 µL/min) to collection, 
and the other that takes a nESI compatible flow rate (0.05 µL/min) to nESI-MS/MS for analysis 




allowing for similar LODs to be obtained while assessing fractions in near-real-time as they are 
generated. The dialysate collected could then be used to validate any interesting results. This will 
also make the method suitable for long-term analysis. A possible limitation to this proposed system 
incurs from the larger droplet fractions generated, which will diminish the sampling rate closer to 
5 – 10 s per fraction as opposed to 0.35 – 0.7 s per fraction. However, while reduction of the 
sampling rate has potential to worsen temporal resolution, it will most likely remain unaffected or 
minimally affected, as axial diffusion before droplet generation is the major source of temporal 
resolution limitation (10 - 11 s) in Chapter 3, not the sampling rate. 
 Finally, this method could offer more information on neurotransmitter dynamics and their 
implications if even 
more compounds 









omitted to improve 
temporal resolution 
by reducing droplet Figure 7-4. Proposed format for “real-time” high temporal resolution in vivo neurochemical monitoring 
using droplet-nESI-MS/MS. A 1:20 split on large dialysis droplets, where the 1 is sent to MS and 20 is sent 




size and because of difficulties achieving sufficient LODs. Including additional neurotransmitters 
of interest (i.e. histamine, histidine, norepinephrine, epinephrine) could provide further insight if 
this method were applied for biological studies. Several steps need to be taken to achieve these 
additions, including increased droplet size and enhanced LODs for the targeted additions, which 
may potentially be obtained through further investigation of buffer additives and diluents 
 
 
SFNE for Rapid Online Sample Clean-up with MS Analysis 
 
 While  the online and continuous SFNE system developed in Chapter 5 proved successful 
for rapidly determining log Kow values for pharmaceutical compounds, SFNE initially 
demonstrated strong applicability for rapid in-line sample clean-up for direct MS analysis, where 
LLEs would occur while in-transit to the ESI source (Chapter 4). While technology for robotic 
sample introduction already exists (i.e. Agilent RapidFire) that can perform in-line SPME and 
achieve sample injection cycles under 10 s, there has been no technology capable of performing 
rapid automated sample introduction in tandem with LLE for MS. As discussed in Chapter 5, 
various online microfluidic LLE techniques exist, but few have been able to achieve rapid sample 
introduction from an array and none of these have been interfaced with MS. Pairing this system 
with MS could offer several uses including MS detection for log Kow determination, where MS 
could provide enhanced sensitivity, specificity, and label-free measurements compared to direct 
UV Vis detection. It could also be used to achieve rapid biological sample screening in applications 
such as drug screening from biofluids or biomarker monitoring in disease states, where biofluids 
can be directly injected into the system for analysis without any additional sample preparation, and 




 Using the system in its current state, samples could be injected with 78 s injection cycles, 
though faster injection cycles could be achieved with different autosamplers as previously 
discussed. There is one key challenge associated with interfacing the LC-SFNE system with MS. 
Ethyl acetate (EtOAc) was identified as the best extraction solvent to be used with ESI, where 
good signal could be obtained when spraying analytes from EtOAc (after extraction) in 
conjunction with 50:50 MeOH/H2O (v/v) from a sheathflow sprayer. However, the devices used 
for SFNE phase pair generation are largely composed of PDMS, which is incompatible with 
EtOAc. In initial tests, EtOAc would rapidly permeate the PDMS, affecting the flow rate, phase 
pair volume ratios, and cause PDMS to swell which would also affect flow rates, or even block 
flow. To overcome this, an entirely glass device mimicking the layout of the original PDMS device 
must be fabricated using hydrofluoric acid etching to create the channels. The glass device may 
then be paired with the autosampler and PFD, EtOAc, and aqueous pumps for phase pair 
generation, extraction, and finally flowed to ESI-MS/MS for analysis.  
 Preliminary experiments were performed to verify the potential capability of this proposed 
system. Glass devices, 
similar to the original 
PDMS devices, were 
fabricated for use with 
EtOAc. During preliminary 
experiments, an LC 
autosampler was not used 
for sample introduction, 
rather an aqueous solution 
Figure 7-5. Preliminary results using online phase pair generation devices with 
aqueous/EtOAc phase pairs. Extraction phase flow begins at 7 min. 1 µM Doxylamine 




comprised of analytes dissolved in water was assessed with and without extractions (Figure 7-5). 
Six drug compounds at 1 µM in pooled human plasma were assessed. Initially, extraction phase 
was not flowing, and aqueous droplets were being formed and sprayed. At 7 min, flow of the 
extraction phase was initiated, upon which phase pairs could form and extractions occur. Signal 
intensity drastically increased when performing ESI on the analytes after extraction into EtOAc, 
where analyte could not be distinguished from baseline noise without extractions. Online phase 
pair formation shows utility for online biofluid clean up and extraction of select compounds for 
MS/MS measurements. Implementing this method for clean-up and identification/quantification 
of drugs from biofluids could offer solutions for rapid drug screening, where several replicates 
could be obtained from a single injection thanks to compartmentalization of many droplets from a 



















Supporting data for in vivo experiments in Chapter 3 
Below is the scheme for droplet generation directly from a microdialysis probe. As 
dialysate and diluent merge in a 50 µm i.d. microfluidic cross at 0.25 µL/min (1:1), they are 
segmented by PFD at 0.5 µL/min to generate reproducible droplet volumes (~5 nL) at 1-3 Hz.  
The cross is a 50 µm i.d. microfluidic cross junction from Valco Instruments Co., Inc with 360 
µm o.d. finger-tight connections. Tightness of these connections on the capillaries/export tubing 
noticeably affects droplet generation in terms of droplet size and reproducibility. Anecdotally, 
incoming flows, which are through 50 µm i.d. x 360 µm o.d. fused silica capillary, should have 
extremely tight connections (by finger-tightening), and the tightness on the export tubing, which 
is 150 µm i.d. x 360 µm o.d. PFA tubing, may be adjusted until ideal droplet generation is 
achieved. When connecting the cross to the probe outlet (360 µm o.d. fused silica capillary), 
extra caution must be taken as the probes are fragile. Making this connection has proven less 


















Figure A-1: Set-up for droplet generation using microfluidic cross-junction attached to microdialysis probe outlet. As diluent and dialysate merge 
(1:1), they are segmented by PFD to form roughply 5 nL droplets with 5 nL PFD spacing into a long line of tubing. 
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Supporting data for in vivo experiments in Chapter 3 
 Below are the individual traces for each biological replicate from in vivo experiments that 
used droplet fractions. The compound, biological replicate (001, 002, 003, 004), and type of 
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